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ABSTRACT
Topics in Multiple Hypotheses Testing. (December 2005)
Yi Qian, B.S., Peking University, China;
M.S., Texas A&M University
Chair of Advisory Committee: Dr. Jeffrey D. Hart
It is common to test many hypotheses simultaneously in the application of statistics.
The probability of making a false discovery grows with the number of statistical tests
performed. When all the null hypotheses are true, and the test statistics are indepen-
dent and continuous, the error rates from the family wise error rate (FWER)- and
the false discovery rate (FDR)-controlling procedures are equal to the nominal level.
When some of the null hypotheses are not true, both procedures are conservative. In
the first part of this study, we review the background of the problem and propose
methods to estimate the number of true null hypotheses. The estimates can be used
in FWER- and FDR-controlling procedures with a consequent increase in power. We
conduct simulation studies and apply the estimation methods to data sets with bio-
logical or clinical significance.
In the second part of the study, we propose a mixture model approach for the
analysis of ChIP-chip high density oligonucleotide array data to study the interac-
tions between proteins and DNA. If we could identify the specific locations where
proteins interact with DNA, we could increase our understanding of many important
cellular events. Most experiments to date are performed in culture on cell lines, bac-
teria, or yeast, and future experiments will include those in developing tissues, organs,
or cancer biopsies, and they are critical in understanding the function of genes and
iv
proteins. Here we investigate the ChIP-chip data structure and use a beta-mixture
model to help identify the binding sites. To determine the appropriate number of
components in the mixture model, we suggest the Anderson-Darling testing. Our
study indicates that it is a reasonable means of choosing the number of components
in a beta-mixture model. The mixture model procedure has broad applications in
biology and is illustrated with several data sets from bioinformatics experiments.
vTo Mom and Dad
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1CHAPTER I
INTRODUCTION
With the increase in genome-wide experiments and the sequencing of multiple genomes,
the analysis of large data sets has become common in biology. It is often the case
in microarray studies that the expression levels of thousands of genes are compared
among different biological states. It is anticipated that proteomic studies (Somorjai,
Dolenko and Baumgartner 2003) will produce an even greater magnitude of multiple
testing problems than those in microarray analysis. Methods based on conventional t
tests provide the probability, α, of a type I error, i.e., the probability that a difference
in gene expression occurred by chance alone. Setting α at the 0.05 level, a microarray
experiment for 10,000 genes would identify 500 genes by chance.
In other applications of statistics, it is also common to test many hypotheses
simultaneously. One application of interest is the multiple endpoints study in clinical
trials, where a new treatment is compared with an existing one in terms of a number
of measurements (endpoints). To control the multiplicity effect, various multiple
comparison procedures have been developed. Shaffer (1995) provided a review of
many of these methods. In general, these procedures intend to maintain the overall
type I error at a specified level by making the individual test criteria more stringent.
This usually reduces the power of a test to detect individual results as significant.
In 1995, Benjamini and Hochberg introduced a new multiple hypothesis testing
error measure, the false discovery rate (FDR), which controls the expectation of the
The format and style follow that of Journal of the American Statistical Association.
2proportion of the false rejections among all the rejections. When all the null hypothe-
ses are true, and the test statistics are independent and continuous, the error rates
from both FWER- and FDR-controlling procedures are controlled at the nominal
level. When some of the null hypotheses are not true, both procedures are conserva-
tive. In the first part of the dissertation, we review some background for the study
and propose methods to estimate the number of true null hypotheses among all the
hypotheses. The estimates can be used in FWER- and FDR-controlling procedures
with a consequent increase in power. We compare our methods with some established
ones in simulation studies and give recommendations for different situations. To il-
lustrate applications, we apply the methods to data sets with biological or clinical
significance.
The second part of the dissertation deals with data sets from bioinformatics
experiments. In order to gain insight into the data sets and discover systematic
structures therein, we present a mixture model approach to describe the distribution
of a set of p-values from bioinformatics experiments. One set of distributions in the
mixture represents results consistent with the null hypotheses, while other distribu-
tions represent results inconsistent with the null hypotheses. Based on the mixture
model, we discuss the estimability of the probability of an alternative hypothesis. In
most cases, this probability is estimable; in cases where it is not estimable, an upper
bound for it may be estimated. To determine the appropriate number of components
included in the model, we suggest a bootstrap method. The proposed method has
broad application in bioinformatics, and we illustrate the use of the approach on
several data sets with biological importance.
3CHAPTER II
MULTIPLE HYPOTHESES TESTING
2.1 Introduction
In the application of statistics, we often test many hypotheses simultaneously. For
example, in clinical studies, we study dosages of a new medicine for treating a cer-
tain disease, and we want to determine at which dosage the medicine is safe and
effective. In the business world, we consider many aspects of a product and want to
know which ones are potentially profitable. In most applications, we are not simply
interested in whether or not all hypotheses are true. Instead, we want to make infer-
ences about individual hypotheses. We want to decide which hypotheses are not true.
A popular application in clinical studies is the multiple endpoints problem, where a
new treatment is compared with an existing one in terms of a number of measure-
ments (endpoints). For example, Paterson et al. (1993) reported on double-blind
controlled trials of oral clodronate in patients with bone metastases from breast can-
cer. They compared eighteen endpoints, such as the number of patients developing
hypercalcemia, the number of episodes when the episodes first appeared, the num-
ber of fractures and morbidity, between the treatment and the control groups. The
researchers were interested in all 18 particular potential benefits of the treatment.
Multiple comparison procedures try to account for the fact that when many
statistical tests are conducted simultaneously, the probability of making at least one
false discovery increases with the number of tests. The traditional method is to
control the probability of falsely rejecting at least one true null hypothesis, the family
wise error rate (FWER). The book by Hsu (1996) and the review paper by Tamhane
(1996) illustrated this idea. The control of the FWER at level α requires each of
4the m individual tests to be conducted at a lower level. This greatly reduces the
power to declare a specific hypothesis as significant when the number of hypotheses
increases. Consequently, we will miss many interesting results. This is probably why
some recommend ignoring the multiplicity issue and testing each hypothesis directly
at the level α. This increases the probability of rejecting null hypotheses that are false,
but also increases the probability of type I errors. Ignoring multiplicity is dangerous,
because researchers will put lots of efforts in exploring results most of which are of no
consequence. Especially in biology, all discoveries are likely to undergo subsequent
verifications, and increased type I errors will cause a waste of time and money. We
can see that not controlling multiplicity is too liberal, but controlling the FWER is
too restrictive.
With the increase in genome-wide experiments and the sequencing of multiple
genomes, it is often the case that thousands of genes are compared over two or more
experimental conditions, where multiple testing issues are important. Some of the
earliest genome-wide analysis involved testing linkage at loci spanning a large portion
of the genome. Since a separate statistical test is performed at each locus, traditional
p-value cut-offs of 0.01 or 0.05 are made stricter to avoid increasing the number of
false positive results. The criterion for statistical significance controls the probability
that one or more false positives occur among all loci tested. This strict criterion
is used mainly because only one or a few loci are expected to show linkage in any
given experiment (Lander and Kruglyak 1995). Due to the development of high-
throughput technologies and genome projects, many more types of genome-wide data
sets are available. The analysis of these data sets involves tests on thousands of
features in the genome, with the expectation that many more than one or two of
them are significant. In these genome-wide tests of significance, protecting against
one or more false positives is too restrictive and leads to many missed findings. In
51995, Benjamini and Hochberg introduced a new multiple-hypothesis testing error
measure with a different goal in mind, that is, to control the proportion of type I
errors among all rejected null hypotheses.
2.2 Testing a single hypothesis
The basic paradigm for testing a single hypothesis is as follows. We test a null
hypothesis H0 versus an alternative H1 based on a statistic T . For a given rejection
region Γ, we reject H0 when T ∈ Γ, and we accept H0 when T 6∈ Γ. A type I error
occurs when T ∈ Γ, but H0 is really true; a type II error occurs when T 6∈ Γ, but H1
is really true. Table 1 describes the possible outcomes from a single hypothesis test.
To define Γ, we ideally choose the test with the lowest type II error probability (β)
while controlling the type I error probability (α) at or below a certain level, i.e. we
maximize the power (power = 1 - β) while maintaining the type I error probability
at a desired level.
Table 1: Possible outcomes when testing a single hypothesis
Accept H0 Reject H0
H0 true Correct Type I error
H0 false Type II error Correct
2.3 Testing multiple hypotheses
When testing multiple hypotheses, the probability of making at least one type I error
among all the tests is considerably higher than the nominal level used on each test.
For example, if α = 0.05, then the probability of making at least one type error among
10 independent tests is 0.37, while the probability of making at least one error among
100 independent tests is greater than 0.99. This naturally leads to various multiple
comparison procedures. In general, these procedures seek to minimize the number of
6type I errors by making the individual tests more conservative. This usually reduces
the power of each individual test.
Table 2 describes the number of various outcomes when applying some significance
rule to m hypothesis tests. Suppose m0 of the null hypotheses are true and m1 of the
null hypotheses are false. We categorize the m tests in the table based on how many
null hypotheses are rejected and how many null hypotheses are true.
Table 2: Number of different outcomes from m hypothesis tests
Hypothesis Accept Reject Total
Null True U V m0
Alternative True T S m1
Total W R m
The most commonly controlled quantity when testing multiple hypotheses is the
family wise error rate (FWER), which is the probability of making at least one false
rejection when all null hypotheses are true. Instead of controlling the probability
of a type I error at level α for each test, the overall FWER is controlled at level α.
Rejection regions for tests are chosen to maintain FWER at level α. The most familiar
example of this is the Bonferroni method. If there are m hypothesis tests, each test
is controlled so that the probability of a false positive is less than or equal to α/m
for some chosen value of α. It follows that the overall FWER is less than or equal
to α. Many more methods, such as Holm’s procedure and Hochberg’s procedure,
have been introduced to improve upon the Bonferroni method. The restrictiveness of
the FWER criterion often leads to multiple testing procedures that have low power.
At the other extreme, some suggest ignoring the multiplicity issue altogether and
testing each hypothesis directly at level α. In most studies, features identified as
being significant will likely undergo subsequent verification. Ignoring the increased
probability of type I errors will cause researchers to put effort into exploring results
most of which are of no consequence, thus leading to a waste of time and money.
72.4 False discovery rate
In practice, the FWER-controlling procedure often yields thresholds that suffer from
low power, and tends not to detect evidence of the most interesting effects. It is
possible that, in a multiple hypothesis testing situation, we are more concerned with
the rate of false rejections among all rejected hypotheses than the probability of
making one or more type I errors. With the increase in genome-wide experiments
and the sequencing of multiple genomes, we have seen an increase in the size of data
sets available, where thousands of hypothesis tests are performed simultaneously. In
this kind of situation, it is too restrictive to protect against one false rejection, and the
total number of false rejections should be taken into account. A practical error rate to
control may be the expected proportion of errors among all the rejected hypotheses,
defined as the false discovery rate (FDR) by Benjamini and Hochberg (1995):
FDR = E
[
V
R ∨ 1
]
= E
[
V
R
| R > 0
]
Pr(R > 0),
where R ∨ 1 = max(R, 1). The effect of R ∨ 1 is to set V/R = 0, when R = 0 and
V = 0. When all the null hypotheses are true, the FDR and FWER criteria are
equivalent. However, when some null hypotheses are false, controlling the FDR offers
a less conservative multiple-testing criterion than FWER, and results in an increase
of power while maintaining the nominal bound on error rate.
For FDR procedures, we choose an acceptable FDR level and find a data-
dependent threshold rule so that the FDR of this rule is less than or equal to the
pre-chosen level. Benjamini and Hochberg (1995) proposed such a rule. They proved
by induction that the following procedure (referred to as the B-H procedure) controls
the FDR at level α when the p-values are independent. Let p(1) ≤ . . . ≤ p(m) be the
ordered set of p-values corresponding to the tested hypotheses. The following steps
describe the B-H procedure:
8• Step 1. Let p(1) ≤ . . . ≤ p(m) be the ordered, observed p-values.
• Step 2. Calculate kˆ = max{k : p(k) ≤ αk/m, 1 ≤ k ≤ m}.
• Step 3. Reject the null hypotheses corresponding to p(1) ≤ . . . ≤ p(kˆ).
This procedure guarantees that
FDR ≤ α,
regardless of how many null hypotheses are true and regardless of the distribution of
the p-values under the alternative.
There are some important properties of the FDR: If all null hypotheses are true,
that is, m0 = m, then the FDR is equal to the FWER. When m0 < m, the FDR
is smaller than or equal to the FWER. Any procedure that controls the FWER also
controls the FDR, and FDR-controlling procedures are more powerful than FWER-
controlling procedures.
The following model is helpful in understanding the FDR-controlling procedures.
Let δm = (δ1, · · · , δm), where δi = 1 if the ith alternative hypothesis (H1i) is true
and δi = 0 if the ith null hypothesis (H0i) is true. We have m0 =
∑m
i=1(1− δi), and
m1 =
∑m
i=1 δi. Let δˆ
m = (δˆ1, · · · , δˆm), where δˆi = 1 if H0i is rejected and δˆi = 0 if H0i
is accepted. Let pi denote the ith p-value. Here we use a random effects model as in
Efron et al. (2001). Specifically we assume the following for 0 ≤ a ≤ 1:
δ1, · · · , δm are i.i.d. Bernoulli(a)
Pi|δi = 0 ∼ Uniform(0, 1)
Pi|δi = 1 ∼ F,
where a = m1/m, and F is a cumulative distribution function (cdf) on [0, 1]. We
then have the distribution of the p-values:
G(t) = (1− a)t + aF (t),
9where F (t) is the cdf for p-values arising from alternative hypotheses. Typical exam-
ples for the class F are parametric families where
Fθ = {Fθ : θ ∈ Θ},
and nonparametric families such as
FC = {F : F concave, absolutely continuous cdf with F (t) ≥ t,∀ t}.
Based on the distribution of the p-values given above, Genovese and Wasserman
(2001) showed that, asymptotically, the B-H procedure corresponds to rejecting the
null when the p-value is less than t∗, where t∗ is the solution to the equation F (t) = βt,
and β = (1 − α + αa)/αa. This t∗ satisfies α/m ≤ t∗ ≤ α for large m, which shows
that the B-H procedure is intermediate to Bonferroni and uncorrected testing.
Besides the FWER and the FDR, there are other error measures in multiple
hypotheses testing. See Table 3 for a summary of those measures.
Table 3: Different measures of error rates in multiple hypotheses testing
Measure of error rate Definition
Family wise error rate (FWER) Pr(V ≥ 1)
False discovery proportion (FDP) V/R
False discovery rate (FDR) E(V/R)
False non-discovery rate (FNR) E(T/W )
Per-comparison error rate (PCER) E(V )/m
Positive false discovery rate (pFDR) E(V/R|R > 0)
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CHAPTER III
USING ESTIMATES OF THE NUMBER OF TRUE NULL HYPOTHESES IN
MULTIPLE HYPOTHESES TESTING
3.1 Introduction
In 1995, Benjamini and Hochberg introduced a new multiple hypothesis testing error
measure, the false discovery rate (FDR). In general, a method which controls the
FDR is more powerful than one which controls the FWER, but the empirical FDR
of the B-H method is still at a level lower than the nominal error rate. So the field is
open for developing procedures to improve the power of the tests.
In multiple hypothesis testing problems, the number of true null hypotheses, m0,
is fixed but unknown. We can develop procedures to estimate m0 and apply the esti-
mates in testing. In this study, we introduce two methods to estimate m0. The p-plot
method is improved and formalized based on the graphical approach by Schweder and
Spjotvoll (1982). The spacing method is based on spacings between order statistics.
We also introduce some computationally intensive methods for estimation of the num-
ber of true null hypotheses. We compare them with some established methods such as
Storey’s method and the lowest slope method proposed by Benjamini and Hochberg
(2000). We illustrate the role of m0 in controlling FWER and FDR. Besides the two
mentioned above, m0 plays a role in other settings as well, for example, m0/m is the
correct prior probability that a null hypothesis is true in Bayesian analysis.
In this chapter, we review some background for our study and set up simulation
studies to compare methods for estimating m0. The estimated number of true null
hypotheses is then used to improve the power of FWER- and FDR-controlling pro-
cedures. The methods are illustrated by some applied examples with biological or
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clinical importance.
3.2 Improving FDR-controlling procedures
Let p(1) ≤ . . . ≤ p(m) be the ordered p-values corresponding to the tested hypotheses.
The procedure of Benjamini and Hochberg’s method (B-H) for controlling FDR is
given in Chapter II.
The proof that the B-H procedure controls the FDR is based on the lemma
(Benjamini and Hochberg 1995) that for any 0 ≤ m0 ≤ m independent test statis-
tics corresponding to true null hypotheses, the multiple test procedure satisfies the
inequality
E
(
V
R
|Pm0+1 = p1, . . . , Pm = pm1
)
≤ m0
m
α,
where for ease of notation Pm0+1, . . . , Pm denote p-values corresponding to false null
hypotheses. Note that the inequality holds regardless of what values are taken on by
Pm0+1, . . . , Pm. Integrating the inequality yields
E
(
V
R
)
≤ m0
m
α ≤ α,
and the FDR is controlled. When all the null hypotheses are true, and the test statis-
tics are independent, the FDR control is sharp at level α; when the number of true
null hypotheses m0 is fewer than m, the procedure is conservative in that it controls
the FDR at level αm0/m. Benjamini and Yekutieli (2001) show that the B-H method
still controls FDR at the nominal level even for dependent tests. Unfortunately, this
is typically very conservative. Sometimes it is even more conservative than Bonferroni
procedures.
The B-H procedure controls the error rate for all values of m0 without using any
information in the data about m0. Often, the power of the multiple hypothesis testing
method, E(S/m1), decreases when the number of hypotheses tested, m, increases.
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This is counter-intuitive, especially when the test statistics are independent. The
larger m is, the more information we have on m0. It seems that information on m0
can lead to a less restrictive procedure and more power in testing. This suggests
applying information on m0 to an FDR-controlling procedure. A similar idea has
already been applied in FWER-controlling procedures, and used in clinical studies.
Suppose m0 is known. An estimate of FDR(t) with rejection region [0, t] (i.e.,
we reject H0 for pi ≤ t) is
F̂DR(t) =
V̂ (t)
R(t)
,
where the observable R(t) is the number of rejections given threshold t, and V (t) is
the number of false rejections given threshold t. V (t) is not observable, but can be
estimated by m0t. We then have an improved FDR-controlling procedure in multiple
comparisons:
• Choose a nominal false discovery rate α.
• Select rejection region [0, t] that maximizes R(t), under the constraint
F̂DR(t) =
m0t
R(t)
≤ α.
Based on Theorem 2 in Benjamini and Hochberg (1995), the FDR controlling proce-
dure given below is the solution to this constrained maximization problem:
• Step 1. Let p(1) ≤ · · · ≤ p(m) be the ordered, observed p-values.
• Step 2. Calculate kˆ = max{k : p(k) ≤ αk/m0, 1 ≤ k ≤ m}.
• Step 3. Reject the null hypotheses corresponding to p(1) ≤ · · · ≤ p(kˆ).
This procedure is more powerful than the original B-H procedure while maintaining
the FDR at α. However, m0 is often unknown in practice. It seems natural that we
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replace m0 by m̂0 in Step 2 and proceed as if m0 were known. The estimate, m̂0, is a
random variable, and the resulting procedure has yet to be proven to control the FDR
at α. In our study, we conduct a simulation study to evaluate different estimation
methods’ performance. A theoretical analysis is yet to be carried out.
3.3 Improving FWER-controlling procedures
A simple procedure that controls the FWER at level α is the Bonferroni procedure
that allows the rejection of the ith null hypothesis in a set of m tests if
pi ≤ α/m.
This adjustment controls tightly for false positives, with the consequence of an ex-
cessive number of false negatives. In bioinformatics, much of the work is exploratory,
so people seldom use the Bonferroni method. Note that once one of the m null hy-
potheses is rejected, it cannot be considered true anymore and the number of true
null hypotheses is m − 1. This idea is well represented in Holm’s step-down pro-
cedure (Holm 1979) that maintains control of the FWER. Let p(i) denote the ith
ordered p-value, and H0i the corresponding null hypothesis, i = 1, . . . ,m. The i
th
null hypothesis, H0i, is rejected if
p(i) ≤ α/(m− i + 1).
We start with the smallest p-value. If the inequality holds for i = 1, H01 is rejected
and we go on to test H02. The rest follows until the inequality does not hold for p(j),
and we accept all the remaining m− j + 1 hypotheses.
Hochberg (1988) introduced a step-up procedure that is similar to Holm’s step-
down procedure. Instead of starting from the lowest p-value, p(1), the procedure starts
from the highest p-value, p(m). We accept H0i, if
p(i) > α/(m− i + 1).
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If the inequality holds for i, H0i is accepted and we go on to test H0(i−1). We continue
the procedure until the inequality is not satisfied for j, and the hypothesis H0j and
all hypotheses with lower p-values are rejected. This method is intermediate between
Benferroni and uncorrected testing. If p(m) through p(2) are all greater than their
respective adjusted cut-offs, then the cut-off for p(1) is α/m : the original Bonferroni
adjusted value. If all the p-values are less than α, all the test statistics are statistically
significant, and the result is the same as uncorrected testing. Hochberg’s procedure
has been shown to be more powerful than Holm’s procedure. However, in clinical
studies, Holm’s procedure is often applied in multiple testing problems, as it is easier
for clinicians to understand.
An estimate of m0, m̂0, can also be used with one of the Bonferroni procedures,
and it will result in an increase in power. For example, in the case of the original
Bonferroni method, if the FWER has to be controlled at the overall level α, the level
α/m̂0 will be used for the individual test instead of α/m with a consequent increase in
power. The Hochberg procedure has also been modified by Hochberg and Benjamini
(1990) as follows:
• Step 1. Given a set of ordered p-values, accept n hypotheses with corresponding
p(i) > α, where i = m− n + 1, . . . ,m.
• Step 2. If p(m−n) ≤ α/min(m̂0, n), we reject H0(m−n) and all the null hypotheses
with smaller p-values, and stop.
• Step 3. If p(m−n) > α/min(m̂0, n), we accept H0(m−n), and increase n by 1.
Repeat Steps 2 & 3.
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3.4 Number of true null hypotheses
3.4.1 The p-plot method
The p-plot method for estimating m0 is motivated by the graphical approach proposed
by Schweder and Spjotvoll (1982). However, there is subjectivity involved in their
method. Here, we formalize the approach by using a sequential test for detecting a
change point in the slope. Also, the original method simply rejects the hypotheses
corresponding to the m−m0 smallest p-values. Simply rejecting null hypotheses with
the m −m0 smallest p-values does not give control over the error rates. So it is not
recommended to do so.
Let m0 be the unknown number of true null hypotheses, and mp be the number
of p-values greater than a particular p. We reject a null hypothesis when the cor-
responding p-value is small. Therefore, for a not too small p-value, assuming little
contribution from non-null cases, we have
E(mp) ≈ m0(1− p),
which means a plot of mp against 1 − p should approximately follow a straight line
with slope m0 for large p values.
If all the null hypotheses are true, i.e., m = m0, and the test statistics are
independent, the observed p-values can be considered as a random sample from the
uniform(0,1) distribution. The plot of mp versus 1 − p should be a line with slope
m + 1 passing through (0, 0) and the point (1,m + 1).
When m0 < m, the p-values corresponding to the false null hypotheses tend to be
smaller than those corresponding to the true null hypotheses. As such, the p-values
concentrate on the right side of the mp against 1−p plot, and the relationship on the
left side of the plot remains approximately linear with slope m0 + 1. Using a suitable
group of the large p-values, we fit a straight line through the origin with slope β̂, and
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we can estimate m0 by m̂0 = β̂ − 1. See examples in Figures 1 & 2. The left side
of each plot lies close to a straight line. The lines given in the figures are drawn by
visual fit.
The question is how many of the largest p(i)’s should be used to fit the line. The
number of p(i)’s used to estimate the slope affects both the bias and the variance of
the estimate. If we include a large number of pi’s in the estimation, the estimator will
have smaller variance, but bigger bias. This is because of the inclusion of p-values
from the true alternative hypotheses. If we include only a few pi’s in the estimation,
we will have smaller bias, but bigger variance. For a fixed p-value, we have the
estimate m̂0 = mp/(1− p). If p is big, we get an approximately unbiased estimator.
Also note that
var(m̂0) = var(mp)/(1− p)2.
If p is too large, this variance will be large.
The problem of selecting a number of identically distributed values from m ob-
served p-values, p1, . . . , pm, can be viewed as a change point problem. We can thus
apply a structural change detection method to find the beginning of the linear part.
As samples from null and alternative hypotheses are mixed, it is not necessary to
apply a delicate method. Here, we use a simple Chow test which has been widely
applied in economics. In economics, a critical question is whether the same model
is appropriate for two potentially different sub-samples. For example, has trade lib-
eralization altered the historical relationship between monetary policy and inflation?
In what year did information technology shift the production parameters associated
with scale economies in financial services? These are questions to which the Chow
test would provide valuable insight. The Chow test statistic is expressed as follows:
Chow =
(RSS −RSS1 −RSS2)/k
(RSS1 + RSS2)/(n1 + n2 − 2k) ,
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Figure 1: Plot of the p-values from multiple endpoints analysis (See Section 3.6.1 for
a description of the data).
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Figure 2: Plot of the p-values from NAEP trial state assessments (See Section 3.6.2
for a description of the data).
19
where RSS is the residual sum of squares for the model, and this refers to the full
sample regression in which slope coefficients are equal across groups; RSS1 and RSS2
are the residual sum of squares from each of the sub-sample regression results; n1 and
n2 are the numbers of observations in each sub-sample; k is the number of restrictions
to be tested, in our case, the number of estimated parameters in the sub-sample re-
gressions. We calculate Chow test statistics on a sequence of breakpoint candidates,
and select the point K with maximal test statistic value. Let the p-value correspond-
ing to the point K be pK . We then use all the p-values that are greater than or equal
to pK for the estimation of the slope (β) on the left side of the plot. An estimate of
m0 is β̂ − 1.
3.4.2 Spacing method
Pyke (1965) reviewed the distribution function of spacings in different cases. In our
study, we apply uniform spacings. Let X1, . . . , Xn be independent uniform random
variables on [0, 1]. The density function of X = (X1, . . . , Xn) is
fX(x1, . . . , xn) =
 1 if 0 ≤ xi ≤ 1 for 1 ≤ i ≤ n,0 otherwise.
Let U = (U1, . . . , Un) be the order statistics of the X
′
is. The density function of U is
fU(u1, . . . , un) =
 n! if 0 ≤ u1 ≤ . . . ≤ un ≤ 1,0 otherwise.
Set U0 = 0 and Un+1 = 1. The spacings of the sample are defined by Di = Ui−Ui−1 for
1 ≤ i ≤ n + 1. Note that D1 + . . . + Dn+1 = 1. The random vector D = (D1, . . . , Dn)
has density function
fD(d1, . . . , dn+1) =
 n! if di ≥ 0 and d1 + . . . + dn+1 = 1,0 otherwise.
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The distribution function of D does not change under any permutation of its coor-
dinates, that is, uniform spacings are exchangeable random variables. This implies
that the distribution function of any spacing Di is equal to that of D1 and the joint
distribution function of any pair (Di, Dj)(i 6= j), is the same as that of (D1, D2).
Using this fact, we can easily obtain, for x, y ≥ 0 and x + y ≤ 1, that
FDi(x) = FD1(x) = FU1(x) = 1− (1− x)n,
and
F(Di,Dj)(x, y) = Pr(U1 ≤ x, U2 − U1 ≤ y)
= n
∫ x
0
{
1−
(
1− y
1− u
)n−1}
(1− u)n−1du
= 1− {(1− x)n + (1− y)n − (1− x− y)n}.
The corresponding density functions are
fDi(x) = n(1− x)n−1,
f(Di,Dj)(x, y) = n(n− 1)(1− x− y)n−2.
Here, we have ordered p-values, p(0), · · · , p(m+1), where p(0) = 0, and p(m+1) = 1. The
largest m0 p-values are likely from the true null hypotheses, that is, uniform(0,1).
Then the gaps, D1, . . . , Dm0+1, are independently and identically fDi distributed with
mean E(Di) = 1/(m0 + 1). Therefore, m0 can be estimated as 1/Ê(Di) − 1, where
Ê(Di) is the sample mean,
∑m+1
j=m+2−i dj/i. The method is phrased as follows:
• Step 1. Use the B-H method at level α. If no hypothesis is rejected, stop.
• Step 2. If there are r rejections, estimate m̂0[k] for k = r + 1, · · · ,m + 1.
• Step 3. Find first k ≥ 2 such that m0[k] > m0[k − 1].
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• Step 4. Estimate m̂0 = min(m,m0[k]), rounding up to the next highest integer.
The first step is to ensure that the procedure controls FDR when m0 = m. The
second step incorporates the idea that once a null hypothesis is rejected, it can not
be considered as true any more and will not be used to estimate the number of true
null hypotheses. This method and the previous one, more or less, assume that all
p-values below a certain value are only from the alternative hypothesis, while in fact
the distribution is a mixture of p-values from null and alternative hypotheses. In
this sense, the mixture modeling approach given in the next chapter might give a
better estimate of the number of true null hypotheses. But the latter approach is
computationally intensive and does not seem to be reasonable for small data sets, for
example, when there are only about 10 to 20 multiple endpoints in clinical studies.
3.4.3 Density estimation
Results from density estimation can be used to estimate m0. In the following two
sections, we discuss these methods, although we do not use them elsewhere in the
dissertation.
3.4.3.1 Density quantile estimation
Zhao and Hart (2000) discussed how to obtain a density estimate from independent
and identically distributed observations by smoothing sample spacings. Here we esti-
mate m0 using mg(1), where g(1) is the probability density function (pdf) of p-values
evaluated at 1. It is obvious that g(1) = (1− a) + af(1) ≥ 1− a, therefore, mg(1) is
a conservative estimator of m0.
Under the mixture model, the marginal distribution of the p-values is G(t) =
(1− a)t + aF (t), with pdf g(t). The quantile function of G is defined as
Q(u) = inf{t : G(t) ≥ u},
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for u ∈ [0, 1]. The quantile density function (qdf) is defined as
q(u) =
d
du
Q(u),
for u ∈ [0, 1]. If the qdf exists,
q(u)g(Q(u)) = 1,
where the function g(Q(·)) is the density quantile function (Parzen 1979).
In multiple hypotheses testing, there exist p-values p1, · · · , pm with distribution
function G. Let ui = i/m and Yi = m(p(i) − p(i−1)). Then Y1, · · · , Ym are approx-
imately independent, and Yi is approximately exponentially distributed with mean
q(i/m), i = 2, · · · ,m. We can regress Yi on u = i/m to estimate q(u), and obtain the
estimation of g(Q(u)). It follows that m̂0 = m ̂g(Q(1)).
Next we briefly discuss regression when the response has an exponential distribu-
tion. Suppose one observes data (xi, Yi), i = 1, · · · , n, where the xi’s are known and Yi
follows an exponential distribution with mean r(xi), i = 1, · · · , n. The log-likelihood
function is
l(r) = −
n∑
i=1
[log r(xi) + Yi/r(xi)].
Given a value of x, x0, r(x) may be represented as
r(x) ≈ exp(c + dx), x ∈ (x0 − h, x0 + h),
for constants c, d, and some small positive number h. The exponential function is
used to ensure that the estimate is positive. A local version of the log-likelihood
function is written as:
lx0(c, d) = −
n∑
i=1
K
(
x0 − xi
h
)
{c + dxi + Yiexp(−(c + dxi))}
for some kernel function K that is unimodal and symmetric about 0. An estimate
of r(x0) is exp(ĉ + d̂x0), where ĉ, d̂ maximize lx0(c, d). It is important to decide on
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an appropriate value for the smoothing parameter h, the bandwidth. Hart (1997)
provides a review of various methods of smoothing parameter selection.
OSCV is a method proposed by Hart and Yi (1998) and in many settings it
turns out to yield a more efficient data-driven smoothing parameter than does or-
dinary cross-validation. The idea underlying OSCV is that one uses different types
of estimators at the cross-validation and estimation stages of the analysis. Suppose
we want to estimate r(x) by r̂h(x), and need to choose the bandwidth h. Consider
a second estimator, r˜b(x), with smoothing parameter b for which one can define a
transformation h = h(b). The estimate of r(x) is defined to be
r̂h(bˆ)(x),
where b̂ is the cross-validation smoothing parameter for the estimate r˜b. For r˜b(xi),
one uses a local estimator based on the data (x1, Y1), · · · , (xi−1, Yi−1), i.e., data on
only one side of the point at which the estimate is to be calculated, and thus the
name one-sided cross-validation. Define the OSCV curve for r˜b by
OSCV (b) =
1
n−m
n∑
i=m+1
(r˜ib(xi)− Yi)2,
where m is some integer that is at least 1, and r˜ib(xi) is a local estimate computed
from the data (xj, Yj) for which xj is strictly less than xi. One then tries to find
a transformation that takes b̂, the minimizer of OSCV (b), into a bandwidth that is
appropriate for r̂h.
By applying OSCV in local exponential regression, we obtain an estimate of
g(Q(1)), and the resulting estimator of m0 is m̂0 = m ̂g(Q(1)).
3.4.3.2 Kernel density estimation
In this subsection, we describe a local bandwidth selection procedure proposed by
Schucany (1995) in order to estimate the pdf of p-values at 1. If we denote the kernel
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function as K(·) and its bandwidth by h, the estimated density at any point t is
f̂(t; h) = (nh)−1
n∑
i=1
K
{
xi − t
h
}
= n−1
n∑
i=1
Kh(xi − t),
where X1, · · · , Xn is a random sample, and Kh(u) = h−1K(u/h). The quality of a
kernel estimate depends less on the shape of K than on the value of its bandwidth
h. It is important to choose an appropriate bandwidth. Small values of h lead to
undersmoothing, while larger h values lead to oversmoothing.
In the analysis of microarray data, g(p) is the density function of the mixture
distribution of p-values. To simplify the computation, we use a simple transformation
x = 1 − p, and denote the new density function as f(x). We can then estimate the
number of true null hypotheses by m̂0 = mf̂(0; h), where f̂(0; h) is the kernel estimate
of the density at 0, which is a left boundary point. Silverman (1986) suggested the
following to account for the boundary bias:
f̂(0; h) = n−1
n∑
i=1
{Kh(xi − 0) + Kh(−xi − 0)}
= (2/n)
n∑
i=1
Kh(xi).
Here we apply a local bandwidth selection procedure proposed by Schucany
(1995). The local density estimate is
f̂(0; h(0)) = (2/n)
n∑
i=1
Kh(0)(0)
= n−1
n∑
i=1
K∗h(0)(0),
where K∗h(·) = 2Kh(·). Due to concerns about variability, here we restrict our atten-
tion to how well the bandwidth estimator works with a second-order estimator. Such
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estimators are commonly used even when the true regression function has more than
two derivatives (Schucany 1995). One can show that for h → 0, n → ∞, nh → ∞
and continuity of f ′′ at 0,
Biash(0) = Wh
2 + O(h3)
V arh(0) = σ
2V/nh + O((nh)−2),
where V =
∫
∞
0
K∗2(z)dz. An asymptotic expression for the expected squared error is
R(0, h) = (Biash(0))
2 + V arh(0).
By minimizing the dominant terms as a function of h, the asymptotically optimal
bandwidth is expressed as
h∗ =
{
σ2V
4nW 2
}1/5
,
For each fixed h, let f˜h(0) be a fourth order kernel estimator with kernel K˜h. Sub-
tracting f˜h(0) from fˆh(0) results in an estimator of the dominant term in Biash(0):
bh(0) = fˆh(0)− f˜h(0) = n−1
n∑
i=1
Kb(0)
where Kb = K
∗
h−K˜∗h and K˜∗h = 2K˜h. Note that bh has the form of a kernel estimator.
It is also shown in Schucany (1995) that as n →∞ and h → 0,
Ebh(0) = Biash(0) + o(Biash(0)).
Therefore, bh(0) can be used as an estimator of Biash(0). Note that Biash(0) has
the structure of a linear regression in powers of h, and we can estimate W using least
squares. We then obtain the optimal bandwidth h∗, and the resulting estimator of
m0 is m̂0 = mfˆ(0; h
∗).
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3.4.4 A mixture model approach
Under the null hypothesis, p-values follows the uniform(0,1) distribution. Under
the alternative hypothesis, p-values follow the distribution function F . Mixture of
beta distributions are flexible enough to allow for approximation of an arbitrary
distribution on [0, 1]. Let {pi, i = 1, . . . ,m} denote a set of p-values. Under the
mixture of beta distributions, if f is the pdf of P , then
f(p) = q0 +
K∑
j=1
qjβ(p|rj, sj),
where β(·|r, s) represents the beta distribution with parameters r, s > 0, qj > 0, and∑K
j=0 qj = 1. The pdf provides a reasonable model for the distribution of p-values.
The parameters of this distribution can be estimated using the EM algorithm. The
parameter estimates change as the number of components varies, and one can use a
bootstrap method to decide the appropriate number of components to be included
in the model. Given a model, one can estimate the number of true null hypotheses
using m̂0 = mq̂0, and an approximation to the variance of m̂0 is
var(m̂0) ≈ mq̂0(1− q̂0).
Therefore, a 95% upper bound on m0 is
mq̂0 + 2
√
mq̂0(1− q̂0).
Due to its computational complexity, we do not evaluate this method in the simulation
study. For details see Chapter IV.
3.4.5 Storey’s method
Storey (2002) suggested the following estimator of m0:
m̂0 = m
1−Gm(r)
1− r
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where r is a tuning parameter, and Gm(·) is the empirical cdf of p-values. The
rationale for this estimator is the same as for the spacing method, namely, the largest
p-values are most likely to correspond to true null hypotheses. For a given rejection
region [0, r], when r is sufficiently close to 1, F (r) ≈ 1, and hence G(r) ≈ (1−a)r+a.
It follows that
1−G(r) ≈ (1− a)(1− r).
As r goes to 1, the interval (r, 1] will contain fewer alternative p-values and the
estimate of m0 will become less conservative. It is conservative in the sense that
m̂0 overestimates the proportion of null hypotheses. The tuning parameter r can
be chosen by minimizing the mean squared error (MSE) of the estimates through a
bootstrap procedure, but doing so is very computationally intensive. Storey (2002)
argued that, in most cases, r = 1/2 will give reasonably good estimates. Efron et
al. (2001) suggested using a variable r which is a fixed quantile of the p-values, say,
the median, denoted by p(m/2). We then estimate
m̂0 = (m−m/2)/(1− p(m/2)).
The above estimator is incorporated in SAM software where the p-values are estimated
by permutation, which avoids specifying the distribution of the test statistic under
the null hypothesis.
3.4.6 Lowest slope method
Benjamini and Hochberg (2000) introduced a stepwise procedure to estimate m0.
This method may be described as follows:
• Step 1. Use the B-H method at level α. If no hypothesis is rejected, stop.
• Step 2. If there are rejections, estimate m0[k] = m+1−k1−p(k) , for k = 1, · · · ,m.
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• Step 3. Find the first k ≥ 2 such that m0[k] > m0[k − 1].
• Step 4. Estimate m̂0 = min(m,m0[k]), rounding up to the next highest integer.
The first step is to ensure that the FDR is controlled when m0 = m. The method is
based on the quantile plot of the p-value versus its rank. Instead of estimating the
slope by least squares, the slope for the largest m + 1− k p-values is estimated from
the line passing through (m + 1, 1) and (k, p(k)). The reciprocal of the slope is then
used as an estimate of m0.
3.5 Simulation study
A simulation study was performed to compare various methods of estimating m0.
Five procedures were investigated here: spacing method (G), lowest slope method
(L), the p-plot method (P), Storey’s method with tuning parameter r = 1/2 (S1),
and with r = p(m/2) (S2). The number of tests m was set at: 16, 32, 64, 128, 256,
512, 1024, 2048. The fraction of the true null hypotheses was: 1, 0.75, 0.50, 0.25. We
tested the m hypotheses H0i : µi = 0 vs. H1i : µi > 0, i = 1, . . . ,m. The p-values
were generated as follows:
• Let Z0, Z1, . . . , Zm be iid N(0, 1).
• Let Yi = √ρZ0 +
√
1− ρZi + µi, for i = 1, · · · ,m.
• Let pi = Φ(Yi), where Φ(·) is the upper percentile of the standard normal.
This generation procedure implies that Corr(Yi, Yj) = ρ for all i 6= j. The correlations
considered were ρ = 0, 0.1, 0.25, 0.5, 0.75. We consider the following two schemes for
the nonzero effect size µi: all µi’s = 5; the µi’s are equally divided among the four
values: 5/4, 2(5/4), 3(5/4), 5. We could also generalize the setting by assuming that
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µi follows a parametric distribution such as Normal(5, 1), which was not included in
this study. The simulation results are based on 10,000 replications.
3.5.1 Results on the estimation of m0
Table 4: Comparisons of the estimates for m0. The total number of hypotheses is
m = 16, 32, 64, 128, m0/m = 0.5, scheme =1, and ρ is the fixed pairwise correlation
ρ = 0 ρ = 0.1 ρ = 0.25 ρ = 0.5 ρ = 0.75
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
m = 16
G 9.05 2.04 9.04 2.58 8.97 3.28 9.07 4.34 9.62 5.23
L 10.48 1.98 10.45 2.48 10.36 3.13 10.37 4.09 10.74 4.89
P 8.22 1.24 8.29 1.54 8.50 2.02 9.07 2.77 10.21 3.33
S1 8.00 2.84 7.98 3.37 7.96 4.11 7.96 5.14 7.97 6.14
S2 9.15 0.40 9.24 0.56 9.38 0.77 9.72 1.16 10.19 1.59
m = 32
G 16.74 1.89 16.72 2.97 16.66 4.82 17.33 7.61 19.09 9.71
L 18.18 1.89 18.18 2.96 18.11 4.77 18.71 7.44 20.30 9.42
P 17.31 2.65 16.95 3.49 16.65 4.76 17.48 7.04 19.88 8.71
S1 15.96 3.99 16.05 5.61 15.92 7.42 16.07 9.85 15.95 12.10
S2 17.16 0.43 17.31 0.69 17.56 1.09 18.26 2.00 19.32 3.00
m = 64
G 32.61 1.78 32.61 3.47 32.36 7.05 33.60 12.53 37.80 17.44
L 34.09 1.78 34.08 3.47 33.83 7.04 35.03 12.44 39.10 17.20
P 35.77 6.52 33.32 8.73 30.74 11.56 30.50 16.49 34.88 20.80
S1 31.93 5.64 32.12 9.70 31.80 13.96 31.95 19.03 32.33 23.77
S2 33.19 0.47 33.41 0.88 33.84 1.61 35.04 3.39 37.25 5.52
m = 128
G 64.62 1.82 64.51 4.32 64.07 10.04 65.48 20.41 74.26 30.96
L 66.11 1.82 65.99 4.31 65.55 10.04 66.95 20.37 75.62 30.75
P 67.65 15.42 61.64 24.38 55.42 30.95 63.25 40.40 67.52 45.63
S1 63.96 8.05 63.99 18.00 63.96 26.86 64.38 37.55 63.76 47.46
S2 65.29 0.59 65.60 1.16 66.28 2.46 68.39 5.84 72.53 10.19
For small and intermediate sample sizes, see Tables 4 and 5. Under independence,
G, P and L perform well. The good performance of S2 is because G2 is calculated
assuming most of the p-values greater than p(m/2) are from the null hypotheses, which
happens to be the setting here. Under a weak correlation, G and P perform well.
As the correlation goes up, the variances of all five estimators increase dramatically,
and G and L perform well. Estimates from P have small biases, but bigger variance.
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Table 5: Comparisons of the estimates for m0. The total number of hypotheses is
m = 16, 32, 64, 128, m0/m = 0.5, scheme =2, and ρ is the fixed pairwise correlation
ρ = 0 ρ = 0.1 ρ = 0.25 ρ = 0.5 ρ = 0.75
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
m = 16
G 9.95 2.22 9.82 2.81 9.63 3.45 9.29 4.33 9.05 5.02
L 11.42 2.15 11.28 2.72 11.07 3.34 10.69 4.22 10.41 4.92
P 9.02 2.37 9.15 2.82 9.38 3.28 9.85 3.83 10.73 3.98
S1 8.48 2.94 8.46 3.63 8.45 4.35 8.33 5.34 8.15 6.22
S2 10.11 1.20 10.37 1.62 10.71 2.00 11.21 2.43 11.67 2.69
m = 32
G 19.08 2.51 18.83 3.88 18.45 5.51 17.82 7.60 17.53 8.93
L 20.58 2.51 20.32 3.87 19.94 5.51 19.30 7.58 19.01 8.94
P 17.84 4.91 17.52 6.30 17.30 7.62 17.25 9.21 18.46 9.81
S1 16.90 4.20 16.91 6.15 16.80 7.98 16.51 10.29 16.35 12.19
S2 19.38 1.64 19.88 2.72 20.60 3.81 21.70 4.95 22.80 5.59
m = 64
G 38.40 3.32 38.07 5.82 37.37 8.97 35.86 13.63 35.21 16.56
L 39.91 3.33 39.57 5.82 38.87 8.96 37.36 13.63 36.71 16.58
P 40.38 10.45 38.53 14.34 35.93 17.64 33.37 21.20 33.67 22.87
S1 33.80 5.99 33.94 10.72 33.61 15.08 32.98 20.19 32.48 24.20
S2 37.83 2.18 38.87 4.51 40.39 7.15 42.79 9.89 45.06 11.32
m = 128
G 78.11 4.61 77.59 9.53 76.00 15.99 73.80 24.91 71.44 31.25
L 79.62 4.61 79.09 9.53 77.50 16.00 75.30 24.90 72.94 31.25
P 78.46 22.38 72.50 32.39 65.18 39.64 68.98 46.28 64.20 47.07
S1 67.65 8.36 67.61 19.75 66.65 29.58 66.42 39.80 63.72 48.22
S2 74.73 2.97 76.80 8.12 79.84 14.02 85.06 19.67 89.18 22.66
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The simulation results for bigger sample sizes are summarized in Tables 6, 7 and
8. Tables also indicate that G and L have the best performance, and estimation
variances increase with the correlation.
Table 6: Comparisons of the estimates for m0. The total number of hypotheses is
m = 2048, m0/m = 1, and ρ is the fixed pairwise correlation
ρ = 0 ρ = 0.1 ρ = 0.25 ρ = 0.5 ρ = 0.75
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 2047.41 1.14 2045.29 17.32 2036.70 77.51 2011.61 211.86 2022.58 212.90
L 2047.84 0.65 2044.67 19.70 2032.48 95.04 1984.48 304.80 1978.14 371.23
P 1863.60 292.66 1364.70 680.43 994.54 769.60 628.36 715.98 368.29 564.17
S1 2029.90 26.14 1835.08 301.80 1705.92 467.91 1533.24 664.91 1367.79 818.16
S2 2030.62 24.88 1890.10 208.37 1832.52 273.12 1782.80 327.51 1755.53 355.43
Table 7: Comparisons of the estimates for m0. The total number of hypotheses is
m = 1024, m0/m = 1, and ρ is the fixed pairwise correlation
ρ = 0 ρ = 0.1 ρ = 0.25 ρ = 0.5 ρ = 0.75
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 1023.42 1.14 1022.07 11.06 1017.92 42.69 1009.29 95.50 1007.91 118.00
L 1023.84 0.64 1021.58 13.07 1014.76 54.28 992.84 152.09 975.56 216.54
P 934.04 143.20 705.82 329.49 539.41 382.51 368.73 380.11 230.89 318.49
S1 1011.20 18.59 917.48 150.88 857.79 231.08 775.25 326.47 686.18 407.56
S2 1011.93 17.55 945.27 103.79 919.26 135.31 895.71 161.16 878.78 177.23
Table 8: Comparisons of the estimates for m0. The total number of hypotheses is
m = 521, m0/m = 1, and ρ is the fixed pairwise correlation
ρ = 0 ρ = 0.1 ρ = 0.25 ρ = 0.5 ρ = 0.75
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 511.44 1.14 510.58 7.16 507.68 25.51 501.98 56.66 503.28 60.15
L 511.85 0.66 510.26 8.40 505.25 33.07 490.52 89.81 481.40 120.58
P 465.82 72.03 367.38 157.44 288.89 188.14 205.45 195.74 142.08 175.82
S1 502.68 13.42 459.37 75.57 426.93 118.21 380.90 166.40 342.58 203.67
S2 503.52 12.17 473.29 51.82 458.88 68.57 444.68 81.80 439.36 88.37
Scheme 2 has its alternative hypotheses clustering closer to the null hypotheses
than scheme 1 does. Because of this, the p-values from the alternative hypotheses
interfere with those from the true null. This introduces further bias in the estimator
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of m0, and all the procedures become more conservative (see examples in Tables 9,
10, and 11).
Table 9: Comparisons of the estimates for m0. The total number of hypotheses
is m = 512, ρ = 0, and scheme refers to different ways of simulating data under
alternative hypothesis
m0 = 384 m0 = 256
Scheme 1 Scheme 2 Scheme 1 Scheme 2
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 385.12 2.16 424.40 6.73 257.19 2.30 323.77 10.75
L 386.63 2.17 425.90 6.73 258.69 2.30 325.27 10.75
P 396.34 75.89 390.48 92.60 262.92 67.07 261.88 89.46
S1 384.13 19.60 391.67 20.17 255.79 16.00 270.46 16.89
S2 385.28 14.08 395.91 14.45 258.34 1.05 296.08 5.73
Table 10: Comparisons of the estimates for m0. The total number of hypotheses
is m = 512, ρ = 0.1, and scheme refers to different ways of simulating data under
alternative hypothesis
m0 = 384 m0 = 256
Scheme 1 Scheme 2 Scheme 1 Scheme 2
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 384.50 8.61 423.12 19.64 256.75 7.50 322.91 28.75
L 386.00 8.61 424.63 19.65 258.26 7.51 324.42 28.75
P 339.44 156.54 338.50 160.83 249.74 127.07 265.05 148.28
S1 379.93 90.70 385.09 92.44 255.71 66.59 271.91 74.61
S2 399.74 62.85 407.42 63.89 259.07 2.79 305.03 30.16
3.5.2 Results on improving FDR-controlling procedures
The estimates of m0 can be used to improve the power of FDR and FWER multiple
testing procedures. We can improve the power of an FDR-controlling procedure by
comparing each p(i) with αi/m̂0. Similarly, in FWER-controlling procedures, without
the independence assumption, testing each individual hypothesis at the level α/m̂0
will yield FWER ≤ α.
The results of the FDR control under independence are shown in Figures 3, 4
and 5. The estimation standard error is about 0.003. The dark solid line is from
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Figure 3: Empirical FDR where the test statistics are independent, the designed FDR
level is 0.1, and m0/m = 0.75. The fitted lines are the linear interpolations of points
at m = 16, 32, 64, 128. The dark solid line is from the original B-H procedure; the red
dashed line is the modified B-H procedure with m̂0 from G; the green dotted line is
the modified B-H procedure with m̂0 from L; the blue dot-dashed line is the modified
B-H procedure with m̂0 from P, the light blue long dashed line is the modified B-H
procedure with m̂0 from S1, the purple solid line is the modified B-H procedure with
m̂0 from S2.
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Figure 4: Empirical FDR where the test statistics are independent, the designed FDR
level is 0.1, and m0/m = 0.5. The fitted lines are the linear interpolations of points
at m = 16, 32, 64, 128. The legends are the same as in Figure 3.
35
20 40 60 80 100 120
0
.0
4
0
.0
6
0
.0
8
0
.1
0
0
.1
2
m
F
D
R
Figure 5: Empirical FDR where the test statistics are independent, the designed FDR
level is 0.1, and m0/m = 0.25. The fitted lines are the linear interpolations of points
at m = 16, 32, 64, 128. The legends are the same as in Figure 3.
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Table 11: Comparisons of the estimates for m0. The total number of hypotheses is
m = 512, ρ = 0.25, and scheme refers to different ways of simulating data under
alternative hypothesis
m0 = 384 m0 = 256
Scheme 1 Scheme 2 Scheme 1 Scheme 2
Method Mean s.d. Mean s.d. Mean s.d. Mean s.d.
G 386.93 20.88 424.73 32.52 258.87 16.05 324.33 43.01
L 383.49 27.80 420.81 40.46 256.13 21.50 320.51 49.88
P 272.91 186.35 263.60 186.66 220.76 161.04 220.99 174.57
S1 366.60 128.59 368.12 131.20 255.83 103.64 268.39 114.83
S2 406.93 79.16 410.88 79.68 260.63 6.94 317.25 53.70
the original B-H procedure; the red dashed line is the modified B-H procedure with
m̂0 from G; the green dotted line is the modified B-H procedure with m̂0 from L;
the blue dot-dashed line is the modified B-H procedure with m̂0 from P, the light
blue long dashed line is the modified B-H procedure with m̂0 from S1, the purple
solid line is the modified B-H procedure with m̂0 from S2. The dark solid line that
represents the FDR from original B-H method is always at the bottom of the graphs.
This indicates that we have better control of FDR if we use the estimation of m0 in
the B-H procedure. It is worth the effort to estimate m0. When the null proportion
is high, L and P perform well. They control the FDR at levels very close to and
yet below 0.1. As the proportion of true null hypotheses (1− a = m0/m) decreases,
G, P, and L perform well with G outperforming the rest. Note that G2 has a good
performance when 1 − a is around 0.5. That is because G2 is calculated assuming
most of the p-values greater than p(m/2) are from the true null hypotheses. As m
increases, the FDR level gets closer to 0.1. S2 becomes more conservative as 1 − a
decreases. Therefore, under independence, it is always good to use P and L. When
1− a is not too high, G would give the best control of FDR.
When there is dependence involved, the size of the variance in estimation of m0
can have an effect on the control of FDR. Figures 5, 6, 7, 8, and 9 present these
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results for ρ = 0, 0.1, 0.25, 0.5, and 0.75. Similarly, the dark solid line is from the
original B-H procedure; the red dashed line is the modified B-H procedure with m̂0
from G; the green dotted line is the modified B-H procedure with m̂0 from L; the blue
dot-dashed line is the modified B-H procedure with m̂0 from P, the light blue long
dashed line is the modified B-H procedure with m̂0 from S1, the purple solid line is
the modified B-H procedure with m̂0 from S2. Without using the estimation of m0,
the original B-H procedure is very conservative and tends to be more conservative
as correlation goes higher. When test statistics are independent, G, P and L control
FDR at levels very close and yet below 0.1 with G outperforming the rest; S2 is very
conservative; S1 does not control FDR. When there is a weak correlation, G and P
perform well. As m increases, P has an even relatively better performance. As the
correlation goes up, G and L control FDR at levels close and yet below 0.1, while S1
and P result in an empirical FDR higher than the nominal rate. Therefore, under
weak correlation, it is safe to use P and G. As the correlation gets stronger, we use
G or L with G resulting in a tighter control for FDR.
3.6 Real data analysis
Here we apply the modified FDR approach to three data sets, and we show an im-
provement in the power of the tests in terms of number of rejections.
3.6.1 Multiple endpoints analysis
Multiple endpoints analysis in clinical trials is one of the most commonly encoun-
tered multiplicity problems. Thrombolysis with recombinant tissue-type plasmino-
gen activator (rt-PA) and anisoylated plasminogen streptokinase activator (APSAC)
in myocardial infarction has been proven to reduce mortality. A new front-loaded
infusion regimen of 100 mg of rt-PA with an initial bolus dose of 15 mg followed
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Figure 6: Empirical FDR where the test statistics are correlated with ρ = 0.1, the
designed FDR level is 0.1, and m0/m = 0.25. The fitted lines are the linear inter-
polations of points at m = 16, 32, 64, 128. The legends are the same as in Figure
3.
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Figure 7: Empirical FDR where the test statistics are correlated with ρ = 0.25,
the designed FDR level is 0.1, and m0/m = 0.25. The fitted lines are the linear
interpolations of points at m = 16, 32, 64, 128. The legends are the same as in Figure
3.
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Figure 8: Empirical FDR where the test statistics are correlated with ρ = 0.5, the
designed FDR level is 0.1, and m0/m = 0.25. The fitted lines are the linear inter-
polations of points at m = 16, 32, 64, 128. The legends are the same as in Figure
3.
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Figure 9: Empirical FDR where the test statistics are correlated with ρ = 0.75,
the designed FDR level is 0.1, and m0/m = 0.25. The fitted lines are the linear
interpolations of points at m = 16, 32, 64, 128. The legends are the same as in Figure
3.
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by an infusion of 50 mg over 30 minutes and 35 mg over 60 minutes has been re-
ported to yield higher patency rates than those achieved with standard regimens of
thrombolytic treatment. The effects of this front-loaded administration of rt-PA ver-
sus those obtained with APSAC on early patency and reocclusion of infarct-related
coronary arteries were investigated by Neuhaus et al. (1992) in a randomized multi-
center trial with 421 patients that have acute myocardial infarction. Four families of
hypotheses were identified in the study:
• (a) Baseline comparison (11 hypotheses).
• (b) Patency of infarct-related artery (8 hypotheses).
• (c) Reocclusion rates of patent infarct-related artery (6 hypotheses).
• (d) Cardiac and other events after the start of thrombolitic treatment (15 hy-
potheses). For example, there were bleeding complications in 31% of 199 pa-
tients given rt-PA versus 45% of 202 patients given APSAC (p = 0.0019); there
were 5 in-hospital deaths (2.4%) in the rt-PA group and 17 deaths (8.1%) in
the APSAC group (p = 0.0095).
In this last family, the significance of the treatment effect on each of the 15 end-points
is given by the p-values that are plotted in Figure 1. Five estimation procedures are
compared: spacing method (G), lowest slope method (L), the p-plot method (P),
Storey’s method with tuning parameters r = 1/2 (S1) and r = p(m/2) (S2). Estimates
of m0 and results of controlling FDR at 0.05 are presented in Table 12. Different
methods give a range of results, and there is a big improvement in terms of number
of rejections when we apply the estimation of m0 in the tests. It is interesting to see
that in this case all p-values less than 0.05 lead to rejection of H0 under G, P, S1,
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Table 12: Comparison of the estimation methods using multiple endpoints data set
B-H G L P S1 S2
Estimate 8 10 8 8 8
Rejection region 0.0095 0.0459 0.0344 0.0459 0.0459 0.0459
# of rejections 4 9 8 9 9 9
and S2. Using the implemented procedures to control for the multiplicity effect in
this case does not result in a loss of power.
3.6.2 NAEP assessments
Williams et al. (1999) discussed the problems of error control in large studies giv-
ing specific attention to problems arising in the National Assessment of Educational
Progress (NAEP). The change in the average eighth-grade mathematics achievement
scores for the 34 states that participated in both the 1990 and the 1992 NAEP Trial
State Assessment is adapted from their study. The changes in specific states are of
interest, since the methods used to enhance mathematics achievements in the indi-
vidual states are not the same. The p-values are plotted in Figure 2. Five estimation
procedures are compared: spacing method (G), lowest slope method (L), the p-plot
method (P), Storey’s method with tuning parameters r = 1/2 (S1) and r = p(m/2)
(S2). Estimates of m0 and results from controlling FDR at 0.05 are presented in
Table 13. Different methods give a range of results, and there is a big improvement
in terms of number of rejections when we apply the estimation of m0. In this case,
some of the large p-values are rejected, for example, using method G, one rejects all
the p-values that are less than 0.20964. In fact, even for the original B-H procedure,
a hypothesis may be rejected even though its p-value is greater than α. For example,
we test 50 hypotheses at level 0.05. Suppose p(50) = 0.5 and m̂0 = 5. Then p(50) is
rejected because p(50) ≤ 0.05(50/5).
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Table 13: Comparison of the estimation methods using NAEP assessments data set
B-H G L P S1 S2
Estimate 6 8 6 4 19
Rejection region 0.00964 0.20964 0.14374 0.20964 0.31162 0.02036
# of rejections 11 26 23 26 28 12
3.6.3 ChIP-chip data set
The genome-wide location analysis method (Ren et al. 2000) allows protein-DNA
interactions to be studied across the entire yeast genome. The method combines a
Chromatin Immunoprecipitation (ChIP) procedure, which is used to study in vivo
protein-DNA interactions (Orlando 2000), with gene array analysis. Cells are fixed
with formaldehyde, and sonication is applied to them. DNA fragments that are
bound to a transcription factor of interest are enriched by immunoprecipitation with
a specific antibody. After reverse of the crosslinking, the enriched DNA is amplified
and labeled with a fluorescent dye using PCR. A sample of DNA that has not been
enriched by immunoprecipitation is amplified and labeled with a different fluorescent
dye using PCR. Both IP-enriched and unenriched DNA are then hybridized to a gene
array.
Researchers have determined how most of the transcriptional regulators encoded
in Saccharomyces cerevisiae associate with genes. This transcriptional regulatory
network can describe potential pathways yeast cells can use to regulate global gene
expression programs (Lee et al. 2002). Here we use the data from a certain transcrip-
tion factor, and five estimation procedures are compared: spacing method (G), lowest
slope method (L), the p-plot method (P), Storey’s method with tuning parameters
r = 1/2 (S1) and r = p(m/2) (S2). Estimates of m0 and results from controlling FDR
at 0.05 are presented in Table 14. As before, there is a big improvement in terms of
number of rejections when we apply the estimation of m0.
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Table 14: Comparison of the estimation methods using ChIP-chip data set
B-H G L P S1 S2
Estimate 2227 2228 2299 1548 1809
Rejection region 0.01134 0.01829 0.01829 0.01768 0.02974 0.02392
# of rejections 695 824 824 814 928 878
3.7 Discussion and conclusions
From this study, we can see that it is worth the extra effort to estimate m0. When we
apply the estimates in testing, the result is an increase in power. Under independence,
we recommend using G, P or L to estimate m0. Under dependence, we recommend
using G and L. In most circumstances, G has the tightest control of the FDR. We could
probably apply the methods to discrete p-values as well. The discreteness might cause
the stopping rule to occur too early, and this leads to a more conservative estimation
of m0. We also note that all procedures are controlled at a lower FDR level when
the correlation increases. This indicates that if we can make use of the correlation
structure, we can further improve the FDR-controlling procedures.
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CHAPTER IV
MODELING P -VALUES WITH FINITE MIXTURE OF BETAS
4.1 Introduction
With the increase in genome-wide experiments and the sequencing of multiple genomes,
the analysis of large data sets has become common in biology. It is often the case
in bioinformatics studies that the abundance levels of thousands of genes or DNA
sequences are compared between different biological states. Through studying gene
expression data, we can identify genes associated with a biological state of interest,
such as cancer cells and normal cells; we can group genes with a similar pattern of be-
havior; we can derive a biological pathway. Besides gene expression data, ChIP-chip
data analysis has also become increasingly popular. The purpose of such analyses
is to study the interactions between proteins and DNA. Interactions between pro-
teins and DNA are fundamental to life. If we could identify the specific locations
where proteins interact with DNA, this would greatly increase our understanding of
many important cellular events. But this area is relatively new and has not yet been
addressed in detail.
Given bioinformatics data sets, researchers, of course, want to answer the ques-
tion, “Which genes are differently expressed under the selected treatment?”, or “Which
DNA sequences are bound in vivo by the transcription factor of interest?” Conse-
quently, thousands of hypothesis tests are conducted, one for each gene or DNA
sequence. The null hypothesis is “there is no difference in expression levels between
the two biological states,” or “the DNA sequence is not a binding site for the tran-
scription factor of interest.” We can apply the FWER- or FDR-controlling procedures
to identify significant results from all the hypothesis tests. However, there are still
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more questions that cannot be answered by simply controlling these two error rates.
For instance, “Given a particular result, what is the probability that it comes from
the null hypothesis?”; or “How can one compare the binding profiles of two chromo-
somes for the same transcription factor of interest?” Sometimes, expert knowledge
can help decide the threshold. For example, biologists might argue that if a calculated
t-statistic is greater than 3, then we have enough evidence to think that the corre-
sponding gene is differentially expressed. Then, given a threshold, we want to answer
questions such as: “What proportion of the rejected genes would have a real difference
in expression, and what proportion would be false leads?” “What proportion of the
non-discoveries would be misses?”
In order to answer these or other similar questions, we propose a beta mixture
distribution based on the beta-uniform mixture (BUM) model of Pounds and Morris
(2003) to model the set of p-values from bioinformatics experiments. Let β(·|r, s)
represent the beta pdf with parameters r, s > 0, that is, for any x ∈ [0, 1],
β(x|r, s) = Γ(r + s)
Γ(r)Γ(s)
xr−1(1− x)s−1.
Note that we can express the uniform pdf as a beta density with parameters r =
s = 1. The shapes of mixtures of beta densities are variable enough to allow for an
approximation of almost any arbitrary density on [0, 1]. In Section 4.2, we study the
estimability of a, where a is the proportion of true alternative hypotheses among all
the hypotheses. Section 4.3 presents the notation and the model. In Sections 4.4
& 4.5, we illustrate the Expectation-Maximization (EM) algorithm used to estimate
the model, and discuss how to determine the appropriate number of distributions
to be included in the model. We then illustrate an application of the method to
several bioinformatics data sets in Section 4.6. We conclude with a discussion and a
description of future work.
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4.2 Estimability
In this section, we study the estimability of a, where a is the proportion of true
alternative hypotheses among all the hypotheses. Under the mixture model, p-values
p1, . . . , pm have cdf G(t) = (1 − a)t + aF (t). Define ρ = 1 − inft∈[0,1] F ′(t). We can
decompose G as follows:
G(t) = (1− a)t + aF (t)
= (1− a)t + a((1− ρ)t + F (t)− (1− ρ)t)
= (1− a + a− aρ)t + aρF (t)− (1− ρ)t
ρ
= (1− a˙)t + a˙ ˙F (t),
where a˙ = aρ, a ≥ a˙ and F˙ (t) = {F (t)−(1−ρ)t}/ρ, which is a cdf. This decomposition
shows that a is estimable if ρ = 1, which means that if inft∈[0,1] F
′(t) = 0, then a is
estimable. If in fact F ′(t) = 0, then
a = 1− inf
t∈[0,1]
G′(t) = 1− inf
t∈[0,1]
g(t),
where g is the probability density function (pdf) of the p-values. If F is concave, then
the infimum is achieved at t = 1, in which case
a = 1− g(1).
In most practical settings, we conduct a one-sided hypothesis test on a location
parameter. We begin by considering F as a Normal(θ, σ) family. For purpose of
illustration, we assume σ is known. Let x¯ be the sample mean of n independent
observations, and consider testing the hypothesis H0 : θ = 0 versus H1 : θ > 0
using a z-test. Let Φ(·) and φ(·) represent the cdf and pdf of the standard normal,
respectively, and let Zp represent the (1 − p)th percentile of the standard normal.
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The density function of the p-values follows from the fact that:
Pr(P ≤ p) = Pr
(
X¯
σ/
√
n
≥ Zp
)
= Pr
(
Z ≥ Zp −
√
n
θ
σ
)
,
= 1− Φ
(
Zp −
√
n
θ
σ
)
,
and hence
fθ(p) = −φ
(
Zp −
√
n
θ
σ
)
dZp
dp
.
Note that
Zp = Φ
−1(1− p)
and hence
dZp
dp
= −1/φ(Zp).
Thus, the density of the p-values is
fθ(p) = φ
(
Zp −
√
n
θ
σ
)
/φ (Zp) .
If infp∈[0,1] fθ(p) = fθ(1) = 0, then a is estimable. Note that Zp=1 = −∞. Then using
L’Hopital’s rule, it is easy to show that fθ(p) → 0 as p → 1.
In practice, it is probably more reasonable to assume a probability distribution
h(θ) for θ than to fix θ at a particular value. We then have the density of the p-values:
f(p) =
∫
∞
0
φ
(
Zp −
√
n
θ
σ
)
/φ (Zp) h(θ)dθ.
Since
φ
(
Zp −
√
n
θ
σ
)
/φ (Zp) ≤ 1,
for all P ≥ 1/2 and all θ, we have
lim
p→1
f(p) =
∫
∞
0
lim
p→1
φ
(
Zp −
√
n
θ
σ
)
/φ (Zp) h(θ)dθ = 0
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by the Dominated Convergence Theorem. Therefore, a is estimable. The same argu-
ment applies to many practical settings.
Suppose we conduct a two-sided hypothesis test, for example, we want to compare
the gene expression level between two types of cancer cells. Here, we consider testing
the hypothesis H0 : θ = 0 versus H1 : θ 6= 0 at the significance level α. The densities
of the p-values is
fθ(p) =
1
2
φ
(
Z p
2
−√nθ
σ
)
/φ
(
Z p
2
)
+
1
2
φ
(
−Z p
2
−√nθ
σ
)
/φ
(
Z p
2
)
,
and
f(p) =
∫
∞
−∞
fθ(p)h(θ)dθ.
We evaluate the density function at 1, and get
f(1) =
∫
∞
−∞
φ
(−√n θ
σ
)
φ(0)
h(θ)dθ.
Note that φ
(−√n θ
σ
)
is maximized at θ = 0, and decreases when θ moves away from
0. Therefore, f(1) will be close to 0 if h(θ) is not concentrated near 0. In this case
we can still make sensible inferences based on the estimation of a˙ in a two-sided
hypothesis test.
4.3 The statistical model
In this section, we present a model for fitting p-values from bioinformatics experi-
ments. Let {pi, i = 1, . . . ,m} denote a set of p-values. Under the mixture of beta
distributions, if f is the density function of pi, then
f(pi) = q0 +
K∑
j=1
qjβ(pi|rj, sj)
for qj > 0 and
∑K
j=0 qj = 1. This pdf provides a reasonable model for the distribution
of p-values. It is expressed as a sum of two terms. All pi’s that represent true null
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hypotheses arise from the first term in the density. The remaining pi’s arise from the
remaining terms in the density. Obviously, if all pi’s are from true null hypotheses,
then K = 0 and q0 = 1.
Next we briefly talk about the BUM model introduced by Pounds and Morris
(2003). In this model:
Pi ∼ q0 + (1− q0)β(·|r, 1),
which is a simple mixture of the uniform distribution and a special case of the beta
distribution where the second beta parameter is fixed at 1. The parameters of this
distribution can be easily estimated by maximum likelihood. This model has been
implemented in R as the Bum-class to model the distribution of a set of p-values from
microarry experiments. Even though this model is easy to compute, it has certain
limitations. For example, as bioinformatics technology develops, more and more data
sets emerge and possess greater variability that cannot be adequately modeled by
BUM (see Figure 10).
Next, we give an interpretation of the finite mixture of betas model. The resulting
model can help answer the questions raised at the beginning of the study, and decide
which results are worth further investigation. It provides an exploratory guide for
follow-up experiments in biology.
In the mixture of betas model, the component K = 0 is the null distribution
that represents those test results from true null hypotheses, and q̂0 is an estimate of
the proportion of true null hypotheses among all the hypotheses. Therefore, mq̂0 is
a natural estimate of m0, the number of true null hypotheses. An approximation to
the variance of m̂0 is
var(m̂0) ≈ mq̂0(1− q̂0).
Given the mixture model, and given that a p-value is observed to be p, we can estimate
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Figure 10: Kernel estimates of the p-value distributions with different transcription
factors.
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the probability that this p-value comes from the null distribution by
q0
q0 +
∑K
j=1 qjβ(p|rj, sj)
.
This is simply an application of Bayes theorem. We can generalize this to calculate
the probability that a value p comes from any of the component distributions. For
example, the probability that p comes from the kth component is
qkβ(p|rk, sk)
q0 +
∑K
j=1 qjβ(p|rj, sj)
.
Given a value for p, we can determine the distribution that most likely gives rise to
p by comparing all these probabilities. Take microarray studies as an example: there
is a p-value corresponding to each gene. Given the gene’s p-value, we can determine
the most probable distribution to which this gene belongs.
Sometimes, expert knowledge in certain fields can help decide a threshold above
which we are willing to declare a result as significant. For example, biologists might
argue that if a t statistic is above 3, they would like to think the corresponding gene
is differently expressed. Then the questions are “What proportion of the significant
genes are likely to be false leads?” or “What proportion of the non-significant genes
are likely to have a real difference in expression levels?” If the p-values can be
appropriately modeled by the BUM model, then it is easy to answer those questions.
The area under the density curve can be divided into four portions: false discoveries,
correct discoveries, false non-discoveries and correct non-discoveries. We show that,
given the finite mixture of betas model, it is also convenient to answer these questions.
Let δm = (δ1, · · · , δm), where δi = 1 if the ith alternative hypothesis (H1i) is true
and δi = 0 if the ith null hypothesis (H0i) is true. Set the threshold for a p-value at
t. Among all the discoveries, the proportion of those genes that are likely to be genes
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with a real difference in expression level can be computed as:
Pr(δi = 1|pi ≤ t) = 1− Pr(δi = 0|pi ≤ t) = 1− Pr(δi = 0 ∩ pi ≤ t)
Pr(pi ≤ t) ,
where Pr(pi ≤ t) is the cdf of the mixture model evaluated at t, and Pr(δi = 0∩ pi ≤
t) = q0t. Similarly, among all the non-discoveries, the proportion of those genes that
are likely to be genes with a real difference in expression level can be computed as:
Pr(δi = 1|pi > t) = 1− Pr(δi = 0|pi > t) = 1− Pr(δi = 0 ∩ pi > t)
Pr(pi > t)
,
where Pr(pi > t) = 1 − Pr(pi ≤ t), and Pr(δi = 0 ∩ pi > t) = q0(1 − t). We can
also compute the power of a test, i.e., the probability that we reject a null hypothesis
when it is actually false:
Pr(pi ≤ t|δi = 1) = Pr(δi = 1 ∩ pi ≤ t)
Pr(δi = 1)
=
Pr(pi ≤ t)− Pr(δi = 0 ∩ pi ≤ t)
Pr(δi = 1)
,
where Pr(δi = 1) = 1− q0. Similarly we could compute the type I error of a test, i.e.
the probability of rejecting a null hypothesis when it is actually true:
Pr(pi ≤ t|δi = 0) = Pr(δi = 0 ∩ pi ≤ t)
Pr(δi = 0)
,
where Pr(δi = 0) = q0.
It seems that, given a model, we can very well answer those questions raised at the
beginning of this study. Here, we are still at the stage of exploratory data analysis.
Our main purpose is to gain insight into the data sets and use the information to
guide the follow-up experiments or discover the essential aspects of the data. Next,
we discuss the estimation of the model and the number of appropriate components
to be included in the model.
We can estimate all parameters in the density function by simply solving the mo-
ment equation as shown in Titterington et al. (1985). We can also obtain the param-
eter estimates by maximizing the likelihood function. It does not take long to realize
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that the set of likelihood equations cannot be solved explicitly. If we knew which beta
distribution each pi came from, we could write the likelihood in a much more tractable
form. By treating each beta component as an individual category, we write the fully
categorized data as {zi} which consists of {pi} and {Ii}, where Ii = {Iik, k = 0, . . . , K}
is an indicator vector of length K with 1 in the position corresponding to the appro-
priate category and zeros elsewhere. Each vector Ii is independently and identically
multinomially distributed with parameters q = (q0, . . . , qK)
′.
Let Ψ = (q0, . . . , qK , θ), and θ = (θ1, . . . , θK), where θi = (ri, si). The likelihood
corresponding to (z1, . . . , zm) can then be written in the form
g(z1, . . . , zm|Ψ) =
m∏
i=1
K∏
k=0
qk
Iikβ(pi|rk, sk)Iik ,
where r0 = s0 = 1. Then the log-likelihood can be written as
l(Ψ) =
m∑
i=1
IT
i
V(q) +
m∑
i=1
IT
i
Ui(θ),
where V(q) has jth component log qj and Ui(θ) has jth component log β(pi|rj, sj).
This emphasizes the interpretation of mixture data as incomplete data, with the
indicator vectors as missing values. In the next section, we describe the EM algorithm
used to solve the maximum likelihood estimation problem.
4.4 The EM algorithm
In this section, we illustrate the Expectation-Maximization (EM) algorithm used to
estimate the model. The EM algorithm is a general method for finding the maximum
likelihood estimate of the parameters of an underlying distribution from a given data
set when the data is incomplete or has missing values. There are two main applications
of the EM algorithm. The first is when the data indeed has missing values due to
problems with or limitations of the observation process. The second is when the
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likelihood function can be simplified by assuming the existence of additional but
missing (or hidden) parameters, which is the case in our application.
The EM algorithm iterates between an expectation (E) step, which computes
the expected value of the log likelihood given the current parameter estimates, and
a maximization (M) step, which computes the maximum likelihood estimates of the
parameters given the data and updates the missing quantities to their expectations.
We first describe the abstract form of the EM algorithm as it is often given in the
literature, for example in Titterington et al. (1985). Let z denote a complete data
set, and the likelihood from z is denoted by
g(z|Ψ).
The EM algorithm generates a sequence {Ψ(j)} of estimates from some initial approx-
imation Ψ(0). Each iteration consists of the following double step:
• E step: Evaluate E[log(z|Ψ)|p, Ψ(j)] = Q(Ψ, Ψ(j));
• M step: Find Ψ = Ψ(j+1) to maximize Q(Ψ, Ψ(j)).
Based on Jensen’s inequality, it is easy to show that
l(Ψ(j+1)) ≥ l(Ψ(j)),
which means the likelihoods are monotonic increasing. In our case, Ii are the missing
quantities, and we have the following:
• E step: Evaluate
Q(Ψ, Ψ(j)) =
m∑
i=1
wi(Ψ
(j))TV(q) +
m∑
i=1
wi(Ψ
(j))TUi(θ),
where
wi(Ψ
(j)) = E(Ii|pi, Ψ(j)).
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That is,
wik(Ψ
(j)) = [wi(Ψ
(j))]k = q
(j)
k β(pi|θ(j)k )/f(pi|Ψ(j)).
• M step: Calculate
q
(j)
k =
1
m
m∑
i=1
wik(Ψ
(j)), k = 1, . . . , K.
The form of the M step for θ is more problem specific, and it corresponds to
maximization of
∑m
i=1 wi(Ψ
(j))TUi(θ) in Q(Ψ, Ψ
(j)).
Here we use the EM algorithm for the calculation of maximum likelihood esti-
mates. Note that there exist competing numerical maximizing methods. The most
familiar ones are Newton-Raphson (NR) and the Method of Scoring (MS). NR and
MS are more complicated, particularly in view of the matrix inversion required, and
there is no guarantee that the likelihoods are monotonic increasing. Titterington et
al. (1985) gave a detailed comparison of different procedures.
In our application, we use the EM algorithm to iteratively maximize the log-
likelihood of the fully categorized data, update the conditional probability that pi
is from the k-th component, and reassign pi to the component with max Îik. The
algorithm is phrased as follows, assuming there are K components:
• 1. Initialize Îik: Use K-means clustering as the partitioning method. Îik = 1 if
and only if ith data belongs to component k, and Îik = 0 otherwise.
• 2. Given Îik, calculate
q̂
(1)
k =
∑m
i=1 Îik
m
,
for k = 1, . . . , K.
• 3. M-step: Substitute Îik for Iik in the log-likelihood of the fully categorized
data, and maximize the resulting quantity with respect to θ. Call the maximiz-
ers {θ̂1, . . . , θ̂K}, where θ̂i = {r̂i, ŝi}.
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• 4. E-step: Given the parameter estimates from the M-step, we update the value
of Ii to its current expectation, E(Ii|pi, Ψ(j)), that is,
Îik(Ψ
(j)) = q̂
(1)
k β(pi|θ(j)k )/
K∑
l=0
q̂
(1)
l β(pi|θ(j)l ).
Define
q̂
(2)
k =
∑m
i=1 Îik
m
.
• 5. Iterate between M-step and E-step until the change in the value of the
log-likelihood is negligible, or until the estimates do not change.
We now briefly describe K-means clustering (Hartigan and Wong 1979). It is an
algorithm for partitioning (or clustering) m data points, p1, . . . , pm, into K disjoint
subsets, Sj, j = 1, . . . , K, so as to minimize the sum-of-squares criterion:
K∑
j=1
∑
pi∈Sj
|pi − p¯j|2,
where p¯j is the average of all the data in cluster j.
The EM algorithm yields the final parameter estimates {r̂k, ŝk, k = 1, . . . , K} and
Îik’s. The value of Îik is the posterior probability that pi comes from the component
k. We assign pi to the component with max Îik.
4.5 Number of components
In this section, we discuss how to determine the appropriate number of distributions
to be included in the model. Assuming that we know the value of K, we can calculate
the maximum likelihood estimate of the parameters from the finite mixture of betas
model, and the distribution function can be determined. One set of distributions in
the mixture represents results consistent with the null hypotheses, while the other
distributions represent results inconsistent with the null hypotheses. The estimated
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parameters change as the number of components K changes. Thus, it is important
to include an appropriate number of components in the model.
We first think of a likelihood ratio test to determine the number of components
to be included in the model. The test statistic is two times the difference of the log
likelihood between (K + 1)-component and K-component models. But in this case
the regularity conditions that were used to derive the asymptotic distribution of the
likelihood ratio test (LRT) are violated. The Taylor series expansion used in deriving
the asymptotic distribution requires that all parameters are inside of the parameter
space, and this is violated when we test qK+1 = 0, which is at the boundary of the
parameter space. Also if we specify H0 by θK−1 = θK , then the Ha-likelihood stays
the same as long as (qK−1 + qK) is the same as the (K − 1)st component probability
in (K − 1)-component model. The Ha-likelihood will not approximate the shape of a
full-rank normal density and the asymptotic theory is invalid.
The Akaike information criterion (AIC) (Akaike 1974) and Bayesian information
criterion (BIC) (Schwarz 1978) are also commonly used to select models. AIC and
BIC are likelihood criteria penalized by the model complexity, that is, the number of
parameters in the model. Let M = {Mi : i = 1, · · · , N} be the candidate parametric
models. Given data p, we maximize the likelihood function separately for each model
Mi and obtain L(p,Mi). Let Ki be the number of parameters in the model Mi. The
BIC criterion is defined as
BIC(Mi) = log L(p,Mi)− 1
2
Ki log(m).
The BIC procedure is to choose the model that maximizes the BIC criterion. This
procedure can be derived as a large-sample version of Bayes procedures for the case of
independent, identically distributed observations and linear models (Schwarz 1978).
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The AIC criterion is defined as
AIC(Mi) = log L(p,Mi)−Ki.
The AIC procedure chooses the model that maximizes the AIC criterion. AIC tends
to include too many components in the mixture and BIC tends to include too few
components. A major problem is that the theoretical justifications for these criteria
rely on the same conditions as the usual asymptotic theory of the LRT.
Alternatively, we consider nonparametric tests such as the Anderson-Darling
(AD) test to assess whether the proposed mixture of betas provides an adequate fit
to the data. The AD test statistic is defined as
AD = m
∫ 1
0
(Fm(t)− t)2
t(1− t) dt,
where Fm is the empirical distribution function of the data. The AD test measures
the distance between the hypothesized model and the empirical distribution. It is
a modification of the Kolmogorov-Smirnov (KS) test, and gives more weight to the
tails than does the KS test.
On deciding the value for K, we can simply compare the AD statistics for the
K-component and (K + 1)-component models. If there is little or no improvement
between the two AD statistics, we think that the K-component model provides an
adequate fit to the data. We can also calculate the critical values by simulating the
empirical distribution of the AD statistic. We start with a K-component model.
We first fit a K-component model to the data and estimate the parameters. Given a
model, we then generate m values from the fitted model, and fit a K-component model
to the generated data. We then calculate the AD statistic based on the generated
data. We repeat this process a large number of times, and then have the empirical
distribution of AD statistic for a distribution with K fitted components. Given the
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empirical distribution of the AD statistic, we can estimate the critical values for the
K-component model by sample quantiles. The following is a detailed procedure to
obtain the critical values for a model with K components:
• 1. Fit the model with K components to the data.
• 2. Use parameter estimates from the model with K components to create a
parametric mixture model, and calculate AD statistic, ADo, where o denotes
original data set.
• 3. Generate B bootstrap samples from the model in Step 2.
• 4. For each of the B bootstrap samples, fit the model with K components, and
calculate AD statistics, ADb, b = 1, . . . , B.
• 5. Given ADb, b = 1, . . . , B, estimate a critical value, CVα, by the (1 − α)
quantile of the ADb, b = 1, . . . , B.
• 6. Compare ADo with CVα. If ADo is greater than CVα, conclude a lack of fit
at the significance level α, and proceed to the model with K +1 components. If
ADo is less than or equal to CVα, we assume that K-component model provides
an adequate fit to the data.
Following this procedure, we can determine the appropriate number of compo-
nents to be included in the model, and subsequently the mixture of betas model.
4.6 Applications to biological data
The proposed method is applied to two data sets from bioinformatics experiments.
The first study is to analyze the microarray data from Golub et al. (1999). The second
is to analyze the data from yeast chromatin immunoprecipitation experiments.
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4.6.1 Golub’s gene expression data
Here, we consider the microarray data from Golub et al. (1999). It consists of the
expression of 3051 genes in 38 leukemia patient samples: 27 with ALL (acute lym-
phoblastic leukemia) and 11 with AML (acute myeloid leukemia). Pre-processing was
done as described in Dudoit et al. (2002).
A uniform distribution (K = 0), a mixture of a uniform and one beta distribution
(K = 1), and a mixture of a uniform and two beta distributions (K = 2) are fitted
to the distribution of p-values (See Figure 11). The two mixtures (K = 1, K = 2) are
close to each other and do not appear to be very different. The AD statistics for the
three models are: 1684.038, 0.4296 and 0.3168. Since there is no big improvement in
terms of AD statistic between K = 1 and K = 2, the K = 1 model seems to provide an
adequate fit. We also perform simulations to obtain the empirical distributions of the
AD statistic under different values of K. Given K, we fit the K component model to
the original p-values. We next draw 1000 bootstrap samples from the model. For each
sample, we fit the K component model again, and calculate AD statistics to assess
the adequacy of the fit of the model to the bootstrap sample. Therefore, we have
1000 AD statistics for each proposed model. See Figures 12 and 13 for the empirical
distributions of AD statistics from the two mixtures (K=1 and K=2). We estimate
critical values (CV) by quantiles of the empirical distributions, and the results are
presented in Table 15. If the AD statistic from the original model is less than the
critical value, we accept the null hypothesis, which indicates that the proposed model
adequately fits the data at the chosen level of significance. As such, we conclude that
a mixture of a uniform and one beta distribution (K=1) is an adequate model for the
distribution of this microarray data set.
Similarly, we fit the BUM model to the p-values and calculate AD statistic and
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CV’s as described above. The results are summarized in Table 15.
Table 15: AD statistics for Golub microarray data analysis
Critical values
K AD statistic α = 0.01 α = 0.05 α = 0.10
0 1684 4.5158 2.5696 1.9545
BUM 0.9098 1.0100 0.7141 0.5924
1 0.4296 0.6115 0.4638 0.4272
2 0.3168 0.4436 0.3842 0.3479
Given K = 1, the parameter estimates for q0, r1, and s1 are 0.485, 0.291, 3.647,
respectively. Based on these estimates, an estimate of the number of null hypotheses,
m0, is mq̂0 = 3051(0.485) = 1480. An approximation to the variance of m̂0 is
var(m̂0) ≈ mq̂0(1− q̂0) = 3051(0.485)(1− 0.485) = 762.
Adding two standard deviations to the estimate of m0, we get 1536, which may be
considered as an approximate upper 95% confidence limit for the number of true null
hypotheses. The model is the sum of a uniform term and a beta term, where the mean
of the beta component in the mixture model is 0.291/(0.291 + 3.647) = 0.074. This
means that among all the differentially expressed genes, the p-value is only 0.074 on
average. In contrast, the mean of the beta component in the estimated BUM model is
0.288/(0.288 + 1) = 0.224, which means among all the differentially expressed genes,
the p-value is 0.224 on average. This seems to be high, and therefore, underestimates
the number of true null hypotheses. The consequence of this underestimation is that
we will overestimate the number of true discoveries and underestimate the number of
false discoveries.
We can calculate the probability that a particular p-value comes from the null
distribution or from the beta distribution. For example, the p-value 0.20 has a 54.3%
chance of coming from the null distribution, with the assumption that K = 1. Simi-
larly, we would expect a p-value of 0.01 to come from the null distribution only 7.5%
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Figure 11: Histogram of the Golub p-values. Fitted models are a uniform distribution
(dotted), a mixture of a uniform and one beta (dashed), and a mixture of a uniform
and two betas (solid).
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Figure 12: Empirical distribution of the AD statistics from K = 1 model. The dashed
vertical line is the AD statistic with K = 1 from the original p-values.
66
AD statistics
R
e
la
tiv
e
 F
re
qu
en
cy
0.1 0.2 0.3 0.4 0.5 0.6
0
2
4
6
8
Figure 13: Empirical distribution of the AD statistics from K = 2 model. The dashed
vertical line is the AD statistic with K = 2 from the original p-values.
67
of the time. We plot the posterior probability of genes being differentially expressed
against their corresponding p-values in Figure 14.
Suppose we believe that all p-values less than 0.05 are worth further study at the
molecular level. Among all of the discoveries, the proportion of those genes that are
likely to be genes with a real difference in expression can be computed as:
Pr(δi = 1 ∩ pi ≤ t)
Pr(pi ≤ t) = 1−
0.485(0.05)
0.485(0.05) + (1− 0.485)B(0.05|0.291, 3.647) ,
where B(p|r, s) is the beta cumulative distribution with parameters r and s evaluated
at p. This probability is 0.931, which means there is about a 6.9% chance that any
randomly selected gene with a p-value less than 0.05 would be a gene from a true null
hypothesis. Similarly, among all non-discoveries, the proportion of those genes that
are likely to be genes with a real difference can be computed as:
Pr(δi = 1|pi > t) = 1− 0.485(1− 0.05)
1− (0.485(0.05) + (1− 0.485)B(0.05|0.291, 3.647)) .
This probability is 0.287, which means there is about a 28.7% chance that any ran-
domly selected gene with a p-value greater than 0.05 would be a gene of real difference
in expression. We can calculate these quantities for any threshold.
4.6.2 Analysis of ChIP-chip experiments
Interactions between proteins and DNA are fundamental to life. They mediate tran-
scription, DNA replication, DNA repair, and many other processes that are central
to every organism. A comprehensive understanding of where enzymes and their reg-
ulatory proteins interact with the genome in vivo will greatly increase our under-
standing of the mechanism and logic of these critical cellular events (Buck and Lieb
2003). Chromatin immunoprecipitation (ChIP) is a procedure used to investigate
interactions between proteins and DNA. Along with DNA microarrays, ChIPs allow
researchers to determine the entire spectrum of in vivo DNA binding sites for any
68
0.0 0.2 0.4 0.6 0.8 1.0
0
.0
0
.2
0
.4
0
.6
0
.8
1
.0
P−values
P
o
st
e
ri
o
r 
pr
ba
bi
lit
y
Figure 14: Posterior probability of genes being differentially expressed.
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given protein. The design and analysis of ChIP-chip experiments are significantly dif-
ferent from the traditional microarray experiments. It is still an area that is relatively
new and has not been addressed in detail. See Figure 15 for a summary of the ChIP-
chip procedure. Because of the nature of the experiments, it is only reasonable to
conduct one-sided tests in the analysis of ChIP-chip data sets. In this subsection, we
use 2308 p-values from the ChIP-chip experiments in budding yeast, Saccharomyces
Cerevisiae.
A uniform distribution (K = 0), a mixture of a uniform and one beta distribution
(K = 1), a mixture of a uniform and two beta distributions (K = 2), and a mixture
of a uniform and three beta distributions (K = 3) are fitted to the distribution of
p-values (See Figure 16). The two mixtures (K = 2, K = 3) do not appear to be
very different. The AD statistics for the models are: 10.2179, 0.7332, and 0.5885 (see
Table 16). We pick the K = 2 model to provide an adequate fit to the data, since the
improvement from K = 2 to K = 3 is small. This is also confirmed by the results in
Table 16.
Table 16: AD statistics for ChIP-chip data analysis
Critical values
K AD statistic α = 0.01 α = 0.05 α = 0.10
1 10.2179 1.3346 1.0396 0.9096
2 0.7332 0.9144 0.7184 0.6502
3 0.5885 0.6325 0.5720 0.5398
The selected K = 2 model has pdf f(p) = 0.659 + 0.165β(p|0.409, 3.912) +
0.176β(p|8.671, 1.150). The mean of the first beta distribution that models differentially
expressed genes is 0.409/(0.409+3.912) = 0.095, which means among all DNA binding
sequences, the p-value is 0.095 on average. For the second beta component, the mean
is 8.671/(8.671 + 1.150) = 0.883, which, in fact, models the p-values from the null
distribution, since our p-values are calculated from one-sided tests. These p-values
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Figure 15: A summary of the ChIP-chip procedure (Buck and Lieb 2004).
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Figure 16: Histogram of the p-values from ChIP-chip experiments. Fitted models
are a uniform distribution (dotted), a mixture of a uniform and one beta (dashed),
a mixture of a uniform and two betas (solid), and a mixture of a uniform and three
betas (dot-dashed).
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correspond to cases where µ < µ0 in the null hypothesis.
Based on the model, an estimate for the number of true null hypotheses, m0, is
m(q̂0 + q̂2) = 2308(0.659 + 0.165) = 1927. Adding two standard deviations to the
estimate of m0, we obtain 1963, which may be considered as an approximate upper
95% confidence limit for the number of true null hypotheses. Because of the extra
clustering of p-values towards 1, some of the established estimation methods for m0
fail in this case. For instance, Storey’s estimators with tuning parameter r = 1/2 or
r = median of all the p-values give estimates m̂0 = m.
Given a model, we can calculate the probability that a particular p-value comes
from the null distribution or from the alternative distribution. For example, the p-
value 0.20 has a 79.1% chance of coming from the null distribution, and a p-value of
0.8 has a nearly 100% chance of being from the null. Table 17 gives the probability
that a DNA sequence corresponding to a particular p-value is a binding site for the
protein. We plot the posterior probability of the DNA sequence being a binding site
for the transcription factor of interest against their corresponding p-values in Figure
17.
Table 17: Probability that a particular p-value is from Ha in ChIP-chip data analysis
Rank p-value Probability
. . . . . . . . .
151 0.0128 0.7118
152 0.0132 0.7079
. . . . . . . . .
301 0.0622 0.4552
302 0.0630 0.4528
. . . . . . . . .
1301 0.6108 0.0154
1302 0.6109 0.0154
. . . . . . . . .
Suppose we believe that all the p-values less than 0.05 are worth further study
at the molecular level. Then among all the discoveries, the proportion of those genes
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that are likely to be genes with a real difference in expression can be computed as:
Pr(δi = 1 ∩ pi ≤ t)
Pr(pi ≤ t) =
0.165B(0.05|0.409, 3.912)
0.659(0.05) + 0.165B(0.05|0.409, 3.912) + 0.176B(0.05|8.671, 1.150) .
This probability is 0.729, which means there is about a 27.1% chance that any ran-
domly selected gene with p-value less than 0.05 would be a gene from a true null
hypothesis. Similarly, among all the non-discoveries, the proportion of those genes
that are likely to be genes with a real difference can be computed as:
Pr(δi = 1|pi > t) =
0.165(1− B(0.05|0.409, 3.912))
1− (0.659(0.05) + 0.165B(0.05|0.409, 3.912) + 0.176B(0.05|8.671, 1.150)) .
This probability is 0.867, which means there is only about an 8.67% chance that any
randomly selected gene with p-value greater than 0.05 would be a gene with a real
difference in expression.
4.7 Discussion and conclusions
Our examples seem to indicate that the AD testing is a reasonable means of choosing
the number of components in the beta mixture model. As for the mixture model-
ing approach, it is more informative than simply controlling FWER or FDR. For
example, given a threshold, we can answer questions such as: “What proportion of
the discoveries would have no real difference in expression?” and “What proportion
of the non-discoveries would be misses?” We can calculate the probability that a
particular p-value comes from each component distribution. We can also interpret
the density function in an empirical Bayesian framework, and obtain the posterior
probability for each given p-value. The analysis is exploratory, and guides follow-up
experiments in biology.
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Figure 17: Posterior probability of DNA sequences being the binding sites for the
transcription factor of interest.
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In most analyses of gene expression data sets, a mixture of a single beta distribu-
tion and the uniform distribution provide an adequate fit. But with the development
of bioinformatics technology, more and more data sets emerge and they show greater
variability that cannot be adequately modeled by a simple mixture (see Figure 10).
It is obvious that many data sets will require extra beta terms in the model. How to
explain these beta components in terms of biological phenomena is something that
will require further investigation.
The proposed method also has broad applications beyond the examples we have
here. One application of interest is the identification of the genes associated with sur-
vival of the patients. Here we give a simple example. This is a Lymphoma/Leukemia
molecular profiling project (Alizadeh et al. 2000). The data can be downloaded from
the NIH website. The original paper sought to explain the clinical heterogeneity
of diffuse large B-cell lymphoma (DLBCL), a common subtype of non-Hodgkin’s
lymphoma, from the gene expression patterns. It was found that 40% of patients re-
sponded well to current therapy and had prolonged survival, while the remainder did
not. It was proposed that this variability reflected a molecular heterogeneity in the
tumors. Using DNA microarrays, a systematic characterization of gene expression in
B-cell malignancies was conducted, and showed that there were differences in gene
expression among the tumors of DLBCL patients. Two molecularly distinct forms of
DLBCL were identified: one type expressed genes characteristic of germinal center
B cells (‘germinal center B-like DLBCL’); and the second type expressed genes nor-
mally induced during in vitro activation of peripheral blood B cells (‘activated B-like
DLBCL’). See Figure 18 for an illustration. The molecular classification of tumors
on the basis of gene expression can thus identify previously undetected and clinically
significant subtypes of cancer.
Here we have the survival time ti and gene expression levels pij for 10 individuals
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Figure 18: Gene expression clusters reflect biological relationships and processes (Al-
izadeh et al. 2000).
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(i = 1, . . . , 40) and 4024 genes (j = 1, . . . , 4024). For each gene, we fit a Cox regression
model:
h(tj) = h0(tj) exp(bjpij),
and test if bj = 0. Figure 19 is the distribution of the resulting 4024 p-values.
By applying mixture modeling, we can gain insight into the data set, identify some
potentially interesting genes, and study them at the molecular level.
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Figure 19: Distribution of the survival p-values.
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CHAPTER V
SUMMARY AND FUTURE RESEARCH
5.1 Summary
The B-H procedure controls the FDR at a pre-specified level α. When all the null
hypotheses are true and the test statistics are independent and continuous, the FDR
is controlled at the exact level α. When some of the null hypotheses are false, the FDR
is controlled at a lower level that is m0/mα, where m0/m is the proportion of true
null hypotheses among all the hypotheses. In Part I, we reviewed the problem and
proposed methods for estimating the number of true null hypotheses. We conducted
simulation studies to compare the proposed methods with some established ones. We
also applied the methods to data sets with biological and clinical significance. Our
study shows that it is worth the extra effort to estimate m0. When we apply the
estimates to testing, the result is an increase in power. Under independence, we
recommend using the spacing method (G), the p-plot method (P) or the lowest slope
method (L) to estimate m0. Under dependence, we recommend use of G and L. In
most circumstances, G gives the tightest control of the FDR. Note that the methods
we compare here do not require much in the way of computing resources. We can
certainly apply some of the more sophisticated methods proposed in the study, but
it is not clear which of those methods is preferred.
With the increase in genome-wide experiments and sequencing of multiple genomes,
analyses of large data sets have become common in biology, and we often conduct
thousands of hypothesis tests simultaneously. In order to gain insight into the data
sets and discover systematic structures therein, in Part II we presented a mixture
model approach to describe the distribution of a set of p-values from bioinformatics
80
experiments. One set of distributions in the mixture represents results consistent
with the null hypotheses, while other distributions represent results inconsistent with
the null hypotheses. We also discussed the estimability of the probability of an al-
ternative hypothesis in the mixture model. In most cases, it is estimable; in cases
where it is not estimable, we can put find an upper bound on that. To determine
the appropriate number of components to be included in the model, we suggested a
bootstrap method, and illustrated the use of the approach on several data sets with
biological importance.
In most analysis of gene expression data sets, a mixture of a beta distribution and
the uniform distribution provides an adequate fit. But as high-throughput technolo-
gies and genome projects become more highly developed, more types of genome-wide
data sets are available, and they have greater variability that cannot be adequately
modeled by a two-component model. One such example is the ChIP-chip data sets
published by Lee et al. (2003). It is obvious that they require extra beta terms in
the models. How to explain these beta components in terms of biological phenomena
posts a challenge to us. Through mixture modeling, we can calculate the proba-
bility that a particular p-value comes from each component distribution. Following
that, we can compare all those probabilities and determine the distribution that most
likely gives rise to a specific p-value. Sometimes, expert knowledge can help decide
the threshold. For example, biologists might argue that if a calculated t-statistic is
greater than 3, then we have enough evidence to think that the corresponding gene
is differently expressed. Then given a threshold, we can answer questions such as:
“What proportion of the rejected genes would have a real difference in expression?”
and “What proportion of the non-discoveries would be misses?” We can also interpret
the density function in an empirical Bayesian framework, and obtain the posterior
probability for each given p-value.
81
5.2 Future research
Our study shows that it is worth the extra effort to estimate m0, and apply the
estimate in testing. Future research includes a theoretical analysis for some of the
suggested methods. We also note that all procedures are controlled at a lower FDR
level when the correlation increases. This indicates that if we can make use of the
correlation structure, we can further improve the FDR-controlling procedures.
The mixture modeling approach is more informative than simply controlling
FWER or FDR, and it has the capability to discover and illustrate essential aspects of
the data. We would like to further study properties of bootstrapping AD statistics to
estimate the number of components to be included in the model. Future research also
includes modeling correlated p-values. In microarray data sets, “clumpy dependence”
holds, which means genes are dependent in small groups such as specific pathways,
and each group is independent of the others (Ghazalpour et al. 2005). In clinical
studies, dependence structure is very common in the multiple endpoints analysis. It
is also of interest to study discrete p-values. When dealing with adverse events (AE)
in clinical trials, each AE only has a few occurrences. Therefore the p-values are
really discrete. These are very interesting questions, and we expect more work in
those areas.
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